{
  "timestamp": "2026-02-13T14:46:22.723660",
  "protocol_id": "SPOTLIGHT (ISN 8951-CL-0301, Phase 3)",
  "is_draft": true,
  "counts": {
    "inclusion": 17,
    "exclusion": 20,
    "atomics": 110
  },
  "quality": {
    "scores": {
      "accuracy": 1.0,
      "completeness": 1.0,
      "compliance": 1.0,
      "provenance": 1.0,
      "terminology": 1.0,
      "overall": 1.0
    },
    "thresholds_met": true,
    "failed_dimensions": [],
    "counts": {
      "total_fields": 224,
      "valid_fields": 224,
      "total_provenance": 74,
      "valid_provenance": 74,
      "total_terminology": 1,
      "valid_terminology": 1
    },
    "issues": {
      "accuracy": [
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_1].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "Inclusion/Exclusion Criteria:\nInclusion Criteria: \nWaivers to the inclusion criteria will NOT be all",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_5].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "the final administration of oxaliplatin and 6 months after the final administration of all \nother st",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_6].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not ",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_7].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministrat",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_9].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_11].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ aden",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_12].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within ",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_15].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "tumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject ",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_16].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "Physical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has pred",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[INC_17].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[EXC_1].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[EXC_2].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomizati",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[EXC_3].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[EXC_10].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersist",
          "suggestion": "Replace with actual extracted value"
        },
        {
          "dimension": "accuracy",
          "severity": "error",
          "fieldPath": "criteria[EXC_11].provenance.textSnippet",
          "message": "Placeholder value detected",
          "value": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nu",
          "suggestion": "Replace with actual extracted value"
        }
      ],
      "completeness": [],
      "compliance": [],
      "provenance": [],
      "terminology": []
    }
  },
  "interpretation_pipeline": {
    "success": true,
    "isDraft": true,
    "totalDurationSeconds": 1242.2107758522034,
    "stagesCompleted": 12,
    "stagesFailed": 0,
    "stagesSkipped": 0,
    "stageDurations": {
      "1": 0.12250208854675293,
      "2": 313.4082341194153,
      "3": 0.01567673683166504,
      "4": 192.33499574661255,
      "5": 0.016083240509033203,
      "6": 0.009984493255615234,
      "7": 0.00618290901184082,
      "8": 0.007354736328125,
      "9": 0.005074977874755859,
      "10": 0.005037546157836914,
      "11": 332.99918937683105,
      "12": 403.2321512699127
    },
    "stageStatuses": {
      "1": "success",
      "2": "success",
      "3": "success",
      "4": "success",
      "5": "success",
      "6": "success",
      "7": "success",
      "8": "success",
      "9": "success",
      "10": "success",
      "11": "success",
      "12": "success"
    },
    "counts": {
      "criteria": 37,
      "atomics": 110,
      "omopConcepts": 0,
      "keyCriteria": 0,
      "estimatedEligiblePopulation": 0
    },
    "feasibility": {
      "success": true,
      "stage": 11,
      "stage_name": "Feasibility Analysis",
      "duration_seconds": 332.9924952983856,
      "funnel_result": {
        "protocolId": "SPOTLIGHT (ISN 8951-CL-0301, Phase 3)",
        "analysisTimestamp": "2026-02-13T14:35:57.189203",
        "isDraft": true,
        "keyCriteria": [
          {
            "keyId": "KC010",
            "category": "primary_anchor",
            "normalizedText": "Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma.",
            "criterionType": "Inclusion",
            "queryableStatus": "fully_queryable",
            "estimatedEliminationRate": 99.9,
            "requiresManualAssessment": false,
            "isKillerCriterion": true,
            "funnelPriority": 1,
            "omopMappings": []
          },
          {
            "keyId": "KC011",
            "category": "primary_anchor",
            "normalizedText": "Subject has radiologically confirmed locally advanced unresectable or metastatic disease within 28 days prior to randomization.",
            "criterionType": "Inclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 60.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": true,
            "funnelPriority": 2,
            "omopMappings": []
          },
          {
            "keyId": "KC002",
            "category": "primary_anchor",
            "normalizedText": "Subject is considered an adult (e.g., \u2265 18 years of age in the US) according to local regulation at the time of signing the informed consent.",
            "criterionType": "Inclusion",
            "queryableStatus": "fully_queryable",
            "estimatedEliminationRate": 20.0,
            "requiresManualAssessment": false,
            "isKillerCriterion": true,
            "funnelPriority": 3,
            "omopMappings": []
          },
          {
            "keyId": "KC013",
            "category": "biomarker",
            "normalizedText": "Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong membranous staining as determined by central IHC testing.",
            "criterionType": "Inclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 60.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": true,
            "funnelPriority": 11,
            "omopMappings": []
          },
          {
            "keyId": "KC014",
            "category": "biomarker",
            "normalizedText": "Subject has a known HER2-negative tumor as determined by local or central testing on a gastric or GEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ tumor.)",
            "criterionType": "Inclusion",
            "queryableStatus": "fully_queryable",
            "estimatedEliminationRate": 20.0,
            "requiresManualAssessment": false,
            "isKillerCriterion": false,
            "funnelPriority": 12,
            "omopMappings": []
          },
          {
            "keyId": "KC025",
            "category": "biomarker",
            "normalizedText": "Subject has known dihydropyrimidine dehydrogenase (DPD) deficiency. (NOTE: Screening for DPD deficiency should be conducted per local requirements.)",
            "criterionType": "Exclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 2.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": false,
            "funnelPriority": 13,
            "omopMappings": []
          },
          {
            "keyId": "KC018",
            "category": "treatment_history",
            "normalizedText": "Subject has received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo-adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as long as it was completed at least 6 months prior to randomization. Subject may have received treatment with herbal medications that have known antitumor activity > 28 days prior to randomization.",
            "criterionType": "Exclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 40.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": true,
            "funnelPriority": 21,
            "omopMappings": []
          },
          {
            "keyId": "KC020",
            "category": "treatment_history",
            "normalizedText": "Subject has received systemic immunosuppressive therapy, including systemic corticosteroids within 14 days prior to randomization. Subjects using a physiologic replacement dose of hydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 mg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.",
            "criterionType": "Exclusion",
            "queryableStatus": "fully_queryable",
            "estimatedEliminationRate": 15.0,
            "requiresManualAssessment": false,
            "isKillerCriterion": false,
            "funnelPriority": 22,
            "omopMappings": []
          },
          {
            "keyId": "KC015",
            "category": "functional",
            "normalizedText": "Subject has ECOG performance status 0 to 1.",
            "criterionType": "Inclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 25.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": true,
            "funnelPriority": 31,
            "omopMappings": []
          },
          {
            "keyId": "KC017",
            "category": "functional",
            "normalizedText": "Subject must meet all of the following criteria based on the centrally or locally analyzed laboratory tests collected within 14 days prior to randomization. In the case of multiple sample collections within this period, the most recent sample collection with available results should be used to determine eligibility.",
            "criterionType": "Inclusion",
            "queryableStatus": "fully_queryable",
            "estimatedEliminationRate": 25.0,
            "requiresManualAssessment": false,
            "isKillerCriterion": true,
            "funnelPriority": 32,
            "omopMappings": []
          },
          {
            "keyId": "KC033",
            "category": "functional",
            "normalizedText": "Subject has known peripheral sensory neuropathy > grade 1 unless the absence of deep tendon reflexes is the sole neurological abnormality.",
            "criterionType": "Exclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 20.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": false,
            "funnelPriority": 33,
            "omopMappings": []
          },
          {
            "keyId": "KC012",
            "category": "functional",
            "normalizedText": "Subject has radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects with only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion must either be outside the field of prior radiotherapy or have documented progression following radiation therapy.",
            "criterionType": "Inclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 10.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": false,
            "funnelPriority": 34,
            "omopMappings": []
          },
          {
            "keyId": "KC004",
            "category": "safety_exclusion",
            "normalizedText": "A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test at Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) and a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of the following conditions applies:",
            "criterionType": "Inclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 51.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": true,
            "funnelPriority": 51,
            "omopMappings": []
          },
          {
            "keyId": "KC031",
            "category": "safety_exclusion",
            "normalizedText": "Subject has significant cardiovascular disease, including any of the following:",
            "criterionType": "Exclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 20.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": false,
            "funnelPriority": 52,
            "omopMappings": []
          },
          {
            "keyId": "KC030",
            "category": "safety_exclusion",
            "normalizedText": "Subject has active infection requiring systemic therapy that has not completely resolved within 7 days prior to randomization.",
            "criterionType": "Exclusion",
            "queryableStatus": "partially_queryable",
            "estimatedEliminationRate": 15.0,
            "requiresManualAssessment": true,
            "isKillerCriterion": false,
            "funnelPriority": 53,
            "omopMappings": []
          }
        ],
        "funnelStages": [
          {
            "stageName": "Disease Indication",
            "stageType": "disease_indication",
            "stageOrder": 1,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 2
          },
          {
            "stageName": "Demographics",
            "stageType": "demographics",
            "stageOrder": 2,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 1
          },
          {
            "stageName": "Biomarker Requirements",
            "stageType": "biomarker_requirements",
            "stageOrder": 3,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 3
          },
          {
            "stageName": "Treatment History",
            "stageType": "treatment_history",
            "stageOrder": 4,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 2
          },
          {
            "stageName": "Performance Status",
            "stageType": "performance_status",
            "stageOrder": 5,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 1
          },
          {
            "stageName": "Lab Criteria",
            "stageType": "lab_criteria",
            "stageOrder": 6,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 3
          },
          {
            "stageName": "Safety Exclusions",
            "stageType": "safety_exclusions",
            "stageOrder": 7,
            "patientsEntering": 0,
            "patientsExiting": 0,
            "eliminationRate": 0.0,
            "cumulativeElimination": 0.0,
            "criteriaCount": 3
          }
        ],
        "populationEstimates": {
          "initialPopulation": 1000000,
          "finalEligibleEstimate": 0,
          "confidenceInterval": {
            "low": 0,
            "high": 0
          },
          "estimationMethod": "deprecated_v1_funnel"
        },
        "killerCriteria": [
          "KC010",
          "KC011",
          "KC013",
          "KC004",
          "KC018",
          "KC015",
          "KC017",
          "KC002"
        ],
        "optimizationOpportunities": [],
        "manualAssessmentCriteria": [
          "KC001",
          "KC003",
          "KC004",
          "KC005",
          "KC006",
          "KC007",
          "KC008",
          "KC009",
          "KC011",
          "KC012",
          "KC013",
          "KC015",
          "KC016",
          "KC018",
          "KC021",
          "KC022",
          "KC023",
          "KC024",
          "KC025",
          "KC026",
          "KC027",
          "KC029",
          "KC030",
          "KC031",
          "KC032",
          "KC033",
          "KC035",
          "KC036",
          "KC037"
        ],
        "siteRankings": [],
        "metadata": {
          "dataSource": "unknown",
          "dataQualityScore": 0.0,
          "estimationConfidence": "low",
          "executionTimeSeconds": 0.0,
          "stagesExecuted": 0,
          "totalCriteriaAnalyzed": 0,
          "overallEliminationRate": 100.0,
          "funnelEfficiencyScore": 50.0
        },
        "errors": [],
        "warnings": []
      },
      "summary": {
        "protocol_id": "SPOTLIGHT (ISN 8951-CL-0301, Phase 3)",
        "total_criteria_analyzed": 37,
        "key_criteria_count": 15,
        "funnel_stages_count": 7,
        "initial_population": 1000000,
        "final_eligible_estimate": 0,
        "overall_elimination_rate": 100.0,
        "killer_criteria": [
          "KC010",
          "KC011",
          "KC013",
          "KC004",
          "KC018",
          "KC015",
          "KC017",
          "KC002"
        ],
        "manual_assessment_count": 29,
        "optimization_opportunities_count": 0
      },
      "classification_metadata": {
        "total_criteria": 37,
        "key_criteria_generated": 37,
        "category_distribution": {
          "administrative": 10,
          "primary_anchor": 3,
          "safety_exclusion": 12,
          "functional": 4,
          "biomarker": 3,
          "treatment_history": 5
        },
        "queryability_distribution": {
          "non_queryable": 11,
          "fully_queryable": 8,
          "partially_queryable": 18
        },
        "model_used": "gemini-2.5-pro"
      }
    },
    "qeb_result": {
      "success": true,
      "stage": 12,
      "stage_name": "QEB Builder",
      "duration_seconds": 403.16130018234253,
      "qeb_output": {
        "protocolId": "SPOTLIGHT (ISN 8951-CL-0301, Phase 3)",
        "version": "1.0",
        "generatedAt": "2026-02-13T14:46:22.626760",
        "therapeuticArea": "Oncology",
        "summary": {
          "totalQEBs": 37,
          "inclusionQEBs": 17,
          "exclusionQEBs": 20,
          "fullyQueryable": 2,
          "llmExtractable": 22,
          "hybridQueryable": 3,
          "screeningOnly": 0,
          "notApplicable": 0,
          "partiallyQueryable": 3,
          "requiresManualReview": 7,
          "totalAtomicsConsolidated": 110,
          "uniqueOmopConcepts": 21,
          "deduplicationRate": 0.8090909090909091,
          "killerCriteriaCount": 2,
          "funnelStagesCount": 7,
          "eligibilitySectionPages": {
            "start": 63,
            "end": 66
          }
        },
        "funnelStages": [
          {
            "stageId": "FS_1",
            "stageName": "Primary Diagnosis & Treatment Line",
            "stageOrder": 1,
            "qebIds": [
              "QEB_INC_10",
              "QEB_INC_11",
              "QEB_EXC_1",
              "QEB_INC_2"
            ],
            "combinedEliminationRate": 99.9,
            "stageDescription": "Confirms patients have the correct cancer type, stage, and are in the first-line treatment setting for advanced disease. This is the broadest initial filter."
          },
          {
            "stageId": "FS_2",
            "stageName": "Tumor Biomarker Profile (CLDN18.2+/HER2-)",
            "stageOrder": 2,
            "qebIds": [
              "QEB_INC_13",
              "QEB_INC_14"
            ],
            "combinedEliminationRate": 70.0,
            "stageDescription": "Verifies the specific molecular characteristics of the tumor required for the investigational therapy (zolbetuximab)."
          },
          {
            "stageId": "FS_3",
            "stageName": "Clinical Performance & Prognostic Assessment",
            "stageOrder": 3,
            "qebIds": [
              "QEB_INC_15",
              "QEB_INC_16",
              "QEB_EXC_15"
            ],
            "combinedEliminationRate": 15.0,
            "stageDescription": "Assesses the patient's overall fitness, functional status, and life expectancy to ensure they are well enough for a Phase 3 trial."
          },
          {
            "stageId": "FS_4",
            "stageName": "Comprehensive Medical History & Contraindications",
            "stageOrder": 4,
            "qebIds": [
              "QEB_EXC_5",
              "QEB_EXC_6",
              "QEB_EXC_7",
              "QEB_EXC_8",
              "QEB_EXC_11",
              "QEB_EXC_12",
              "QEB_EXC_14",
              "QEB_EXC_16",
              "QEB_EXC_19"
            ],
            "combinedEliminationRate": 10.0,
            "stageDescription": "A detailed review of the patient's medical history for significant comorbidities, prior allergies, and specific contraindications to the study drugs (zolbetuximab or mFOLFOX6)."
          },
          {
            "stageId": "FS_5",
            "stageName": "Recent Interventions & Active Conditions",
            "stageOrder": 5,
            "qebIds": [
              "QEB_EXC_2",
              "QEB_EXC_3",
              "QEB_EXC_4",
              "QEB_EXC_9",
              "QEB_EXC_10",
              "QEB_EXC_13",
              "QEB_EXC_17"
            ],
            "combinedEliminationRate": 8.0,
            "stageDescription": "Checks for recent major medical procedures, therapies, or active conditions that could interfere with study participation or safety."
          },
          {
            "stageId": "FS_6",
            "stageName": "Screening Labs & Imaging Confirmation",
            "stageOrder": 6,
            "qebIds": [
              "QEB_INC_12",
              "QEB_INC_17"
            ],
            "combinedEliminationRate": 5.0,
            "stageDescription": "Confirms eligibility based on results from screening-specific procedures, including blood tests for organ function and imaging for evaluable disease."
          },
          {
            "stageId": "FS_7",
            "stageName": "Informed Consent & Study Commitments",
            "stageOrder": 7,
            "qebIds": [
              "QEB_INC_1",
              "QEB_INC_3",
              "QEB_INC_4",
              "QEB_INC_5",
              "QEB_INC_6",
              "QEB_INC_7",
              "QEB_INC_8",
              "QEB_INC_9",
              "QEB_EXC_18",
              "QEB_EXC_20"
            ],
            "combinedEliminationRate": 2.0,
            "stageDescription": "Finalizes patient eligibility by obtaining informed consent and confirming the patient's ability and willingness to comply with all study requirements, including contraception."
          }
        ],
        "queryableBlocks": [
          {
            "qebId": "QEB_INC_1",
            "originalCriterionId": "INC_1",
            "criterionType": "inclusion",
            "clinicalName": "Signed Informed Consent and Privacy Authorization",
            "clinicalDescription": "The patient or their legal representative must sign the consent form before any study activities can begin.",
            "clinicalCategory": "Administrative / Regulatory",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
            "sqlLogicExplanation": "A0001",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "Consent is a prospective, administrative process documented outside of standard EHR data fields at the time of enrollment.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0001"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent and privacy language as per national regulations (e.g., HIPAA Authorization for US sites) must be obtained from the subject or legally authorized representative (if applicable) prior to any study-related procedures.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "Inclusion/Exclusion Criteria:\nInclusion Criteria: \nWaivers to the inclusion criteria will NOT be allowed.\nGeneral Criteria:\n1. Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written \ninformed consent and privacy language as per national regulations (e.g., Health Insurance \nPortability and Accountability Act [HIPAA] Authorization for US sites) must be obtained from \nthe subject or legally authorized representative (if applicable) prior to any study-related \nproced..."
            },
            "clinicalSummary": {
              "conceptGroups": [],
              "screeningOnlyRequirements": [
                {
                  "atomicId": "A0001",
                  "description": "IRB/IEC approved written informed consent and privacy language obtained from subject or legally authorized representative",
                  "note": "Site/documentation requirement, not patient filter"
                }
              ],
              "clinicalLogicSummary": "No queryable clinical concepts identified."
            }
          },
          {
            "qebId": "QEB_INC_2",
            "originalCriterionId": "INC_2",
            "criterionType": "inclusion",
            "clinicalName": "Adult Age Requirement",
            "clinicalDescription": "The patient must be legally considered an adult in their country, typically 18 years or older.",
            "clinicalCategory": "Demographics",
            "funnelStage": "Primary Diagnosis & Treatment Line",
            "funnelStageOrder": 1,
            "combinedSql": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
            "sqlLogicExplanation": "A0002",
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": null,
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0002"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [
              {
                "conceptId": 4265453,
                "conceptName": "Age",
                "domain": "Observation",
                "vocabularyId": "SNOMED",
                "conceptCode": "397669002"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|30525-0"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Age",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:397669002 (domain: Observation)",
                "sourceOmopConceptId": 4265453
              }
            ],
            "protocolText": "Subject is considered an adult (e.g., \u2265 18 years of age in the US) according to local regulation at the time of signing the informed consent.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "the subject or legally authorized representative (if applicable) prior to any study-related \nprocedures.\n2. Subject is considered an adult (e.g., \u2265 18 years of age in the US) according to local regulation\nat the time of signing the informed consent.\n3. Subject agrees not to participate in another interventional study while on study treatment."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Age >= 18 years at the time of signing informed co...",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0002"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Age >= 18 years at the time of signing informed consent"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Age >= 18 years at the time of signing informed co..."
            }
          },
          {
            "qebId": "QEB_INC_3",
            "originalCriterionId": "INC_3",
            "criterionType": "inclusion",
            "clinicalName": "No Concurrent Interventional Study Participation",
            "clinicalDescription": "The patient must agree not to take part in any other clinical trials involving an investigational treatment.",
            "clinicalCategory": "Concurrent Therapy / Procedures",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "(SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "NOT (A0003)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Participation in other interventional studies is not reliably captured in a structured way in the EHR and requires a patient interview.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0003"
            ],
            "atomicCount": 1,
            "internalLogic": "NOT",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject agrees not to participate in another interventional study while on study treatment.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "at the time of signing the informed consent.\n3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:"
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Participation in another interventional study",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0003"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Participation in another interventional study"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Participation in another interventional study"
            }
          },
          {
            "qebId": "QEB_INC_4",
            "originalCriterionId": "INC_4",
            "criterionType": "inclusion",
            "clinicalName": "Female Contraception and Pregnancy Status",
            "clinicalDescription": "Female patients must have a negative pregnancy test and meet specific criteria regarding their ability to have children.",
            "clinicalCategory": "Reproductive Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "(((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957)) UNION ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) INTERSECT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957))) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "(NOT (A0004) OR A0005 AND A0006) AND A0007",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "Requires a point-of-care pregnancy test at screening and a prospective agreement from the patient about contraception. Historical data is insufficient.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0004",
              "A0005",
              "A0006",
              "A0007"
            ],
            "atomicCount": 4,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 42528957,
                "conceptName": "Pregnancy status",
                "domain": "Observation",
                "vocabularyId": "LOINC",
                "conceptCode": "82810-3"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|82810-3,77386006"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Pregnancy status",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
                "sourceOmopConceptId": 42528957
              }
            ],
            "protocolText": "A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test at Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) and a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of the following conditions applies:",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3"
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Pregnancy Status",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0004",
                    "A0005",
                    "A0006"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Positive serum pregnancy test OR Positive serum pregnancy test OR Demonstrated non-pregnant status through additional testing"
                },
                {
                  "groupName": "At least one of the other specified conditions app...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0007"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "At least one of the other specified conditions applies"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Pregnancy Status, At least one of the other specified conditions app..."
            }
          },
          {
            "qebId": "QEB_INC_5",
            "originalCriterionId": "INC_5",
            "criterionType": "inclusion",
            "clinicalName": "Agreement to Refrain from Breastfeeding",
            "clinicalDescription": "Female patients must agree not to breastfeed during the study and for a specified time after the last dose.",
            "clinicalCategory": "Reproductive Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation)) UNION ((-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation) INTERSECT (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE))",
            "sqlLogicExplanation": "IF (A0008) THEN (A0009)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Requires a prospective agreement from the patient, which is not captured in historical EHR data.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0008",
              "A0009"
            ],
            "atomicCount": 2,
            "internalLogic": "IMPLICATION",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Female subject must agree not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "the final administration of oxaliplatin and 6 months after the final administration of all \nother study drugs.\n5. Female subject must agree not to breastfeed starting at Screening and throughout the study \nperiod, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other stu..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Female",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0008"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Female"
                },
                {
                  "groupName": "Agrees not to breastfeed starting at Screening and...",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0009"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Agrees not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Female AND Agrees not to breastfeed starting at Screening and..."
            }
          },
          {
            "qebId": "QEB_INC_6",
            "originalCriterionId": "INC_6",
            "criterionType": "inclusion",
            "clinicalName": "Agreement to Refrain from Donating Ova",
            "clinicalDescription": "Female patients must agree not to donate eggs during the study and for a specified time after the last dose.",
            "clinicalCategory": "Reproductive Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (-- Unknown table: person\n-- Atomic text: Female subject\n-- Requires manual SQL generation)) UNION ((-- Unknown table: person\n-- Atomic text: Female subject\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)))))",
            "sqlLogicExplanation": "IF (A0010) THEN (NOT ((A0011 OR A0012 OR A0013)))",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Requires a prospective agreement from the patient, which is not captured in historical EHR data.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0010",
              "A0011",
              "A0012",
              "A0013"
            ],
            "atomicCount": 4,
            "internalLogic": "COMPLEX",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Female subject must not donate ova starting at Screening and throughout the study period, and for 9 months after the final administration of oxaliplatin and 6 months after the final administration of all other study drugs.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Ova Donation",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0011",
                    "A0012",
                    "A0013"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Donate ova OR Donate ova OR Donate ova"
                },
                {
                  "groupName": "Female subject",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0010"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Female subject"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Ova Donation, Female subject"
            }
          },
          {
            "qebId": "QEB_INC_7",
            "originalCriterionId": "INC_7",
            "criterionType": "inclusion",
            "clinicalName": "Male Contraception Requirement",
            "clinicalDescription": "Male patients with female partners who can get pregnant must agree to use specific contraception during the study.",
            "clinicalCategory": "Reproductive Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT ((-- Unknown table: person\n-- Atomic text: Male subject\n-- Requires manual SQL generation) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957))) UNION (((-- Unknown table: person\n-- Atomic text: Male subject\n-- Requires manual SQL generation) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957)) INTERSECT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)))",
            "sqlLogicExplanation": "IF (A0014 AND A0015 AND A0016) THEN (A0017)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Requires a prospective agreement from the patient, which is not captured in historical EHR data.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0014",
              "A0015",
              "A0016",
              "A0017"
            ],
            "atomicCount": 4,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 42528957,
                "conceptName": "Pregnancy status",
                "domain": "Observation",
                "vocabularyId": "LOINC",
                "conceptCode": "82810-3"
              },
              {
                "conceptId": 600058216,
                "conceptName": "Other Investigational Agent",
                "domain": "Observation",
                "vocabularyId": "NCIt_Full",
                "conceptCode": "C156875"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|82810-3,77386006"
                },
                "description": null
              },
              {
                "resourceType": "MedicationStatement",
                "searchParams": {
                  "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Pregnancy status",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
                "sourceOmopConceptId": 42528957
              },
              {
                "conceptName": "Other Investigational Agent",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.7,
                "rationale": "Mapped from OMOP NCIt_Full:C156875 (domain: Observation)",
                "sourceOmopConceptId": 600058216
              }
            ],
            "protocolText": "A sexually active male subject with female partner(s) who are of childbearing potential must agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during the treatment period and for at least 6 months after the final study drug administration.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Male subject",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0014"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Male subject"
                },
                {
                  "groupName": "Sexually active",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0015"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Sexually active"
                },
                {
                  "groupName": "Has female partner(s) of childbearing potential",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0016"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Has female partner(s) of childbearing potential"
                }
              ],
              "screeningOnlyRequirements": [
                {
                  "atomicId": "A0017",
                  "description": "Agrees to use a condom during the treatment period and for at least 6 months after the final study drug administration",
                  "note": "Site/documentation requirement, not patient filter"
                }
              ],
              "clinicalLogicSummary": "Patient must meet: Male subject, Sexually active, Has female partner(s) of childbearing potential"
            }
          },
          {
            "qebId": "QEB_INC_8",
            "originalCriterionId": "INC_8",
            "criterionType": "inclusion",
            "clinicalName": "Agreement to Refrain from Donating Sperm",
            "clinicalDescription": "Male patients must agree not to donate sperm during the study and for a specified time after the last dose.",
            "clinicalCategory": "Reproductive Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (-- Unknown table: person\n-- Atomic text: Sex is Male\n-- Requires manual SQL generation)) UNION ((-- Unknown table: person\n-- Atomic text: Sex is Male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))))",
            "sqlLogicExplanation": "IF (A0018) THEN (NOT (A0019))",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Requires a prospective agreement from the patient, which is not captured in historical EHR data.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0018",
              "A0019"
            ],
            "atomicCount": 2,
            "internalLogic": "COMPLEX",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Male subject must not donate sperm starting at Screening and throughout the study period and for 6 months after the final study drug administration.",
            "provenance": {
              "pageNumber": 24,
              "sectionId": null,
              "textSnippet": "agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study period and \nfor 6 months after the final study drug administration."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Sex is Male",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0018"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Sex is Male"
                },
                {
                  "groupName": "Sperm donation",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0019"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Sperm donation"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Sex is Male, Sperm donation"
            }
          },
          {
            "qebId": "QEB_INC_9",
            "originalCriterionId": "INC_9",
            "criterionType": "inclusion",
            "clinicalName": "Male Contraception with Pregnant/Breastfeeding Partner",
            "clinicalDescription": "Male patients whose partner is pregnant or breastfeeding must agree to use a condom or abstain from sex.",
            "clinicalCategory": "Reproductive Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT ((-- Unknown table: person\n-- Atomic text: Subject is male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957)))) UNION (((-- Unknown table: person\n-- Atomic text: Subject is male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957))) INTERSECT ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))))",
            "sqlLogicExplanation": "IF (A0020 AND (A0021 OR A0022)) THEN ((A0023 OR A0024))",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Relies on information about a non-patient (the partner) and a prospective agreement from the patient.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0020",
              "A0021",
              "A0022",
              "A0023",
              "A0024"
            ],
            "atomicCount": 5,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 42528957,
                "conceptName": "Pregnancy status",
                "domain": "Observation",
                "vocabularyId": "LOINC",
                "conceptCode": "82810-3"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|82810-3,77386006"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Pregnancy status",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
                "sourceOmopConceptId": 42528957
              }
            ],
            "protocolText": "Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent or use a condom for the duration of the pregnancy or for the time partner is breastfeeding throughout the study period and for 6 months after the final study drug administration.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Partner Status",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0021",
                    "A0022"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Partner is pregnant OR Partner is breastfeeding"
                },
                {
                  "groupName": "Subject is male",
                  "clinicalCategory": "demographics",
                  "atomicIds": [
                    "A0020"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Subject is male"
                }
              ],
              "screeningOnlyRequirements": [
                {
                  "atomicId": "A0023",
                  "description": "Agrees to remain abstinent for the required duration",
                  "note": "Site/documentation requirement, not patient filter"
                },
                {
                  "atomicId": "A0024",
                  "description": "Agrees to use a condom for the required duration",
                  "note": "Site/documentation requirement, not patient filter"
                }
              ],
              "clinicalLogicSummary": "Patient must meet: Partner Status, Subject is male"
            }
          },
          {
            "qebId": "QEB_INC_10",
            "originalCriterionId": "INC_10",
            "criterionType": "inclusion",
            "clinicalName": "Histologically Confirmed Gastric or GEJ Adenocarcinoma",
            "clinicalDescription": "The patient must have a tissue biopsy confirming a diagnosis of stomach or gastroesophageal junction cancer.",
            "clinicalCategory": "Disease Indication",
            "funnelStage": "Primary Diagnosis & Treatment Line",
            "funnelStageOrder": 1,
            "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
            "sqlLogicExplanation": "A0025 AND (A0026 OR A0027)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "While diagnosis codes for gastric cancer exist, confirming the specific histological subtype (adenocarcinoma) often requires NLP on pathology reports or manual chart review.",
            "estimatedEliminationRate": 99.9,
            "isKillerCriterion": true,
            "epidemiologicalEvidence": "SEER Cancer Stat Facts: Stomach Cancer. National Cancer Institute. The age-adjusted incidence rate is ~6.7 per 100,000 persons per year in the US.",
            "atomicIds": [
              "A0025",
              "A0026",
              "A0027"
            ],
            "atomicCount": 3,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 196044,
                "conceptName": "Primary malignant neoplasm of stomach",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "372014001"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|372014001,C16.9"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Primary malignant neoplasm of stomach",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:372014001 (domain: Condition)",
                "sourceOmopConceptId": 196044
              }
            ],
            "protocolText": "Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Gastric Or Gej Adenocarcinoma",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0026",
                    "A0027"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Gastric adenocarcinoma OR Gastroesophageal junction (GEJ) adenocarcinoma"
                },
                {
                  "groupName": "Histologically confirmed diagnosis",
                  "clinicalCategory": "diagnostic_confirmation",
                  "atomicIds": [
                    "A0025"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Histologically confirmed diagnosis"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Gastric Or Gej Adenocarcinoma, Histologically confirmed diagnosis"
            }
          },
          {
            "qebId": "QEB_INC_11",
            "originalCriterionId": "INC_11",
            "criterionType": "inclusion",
            "clinicalName": "Confirmed Advanced or Metastatic Disease",
            "clinicalDescription": "The patient's cancer must be confirmed by imaging scans to be advanced, not removable by surgery, or spread to other parts of the body.",
            "clinicalCategory": "Disease Stage / Extent",
            "funnelStage": "Primary Diagnosis & Treatment Line",
            "funnelStageOrder": 1,
            "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND o.observation_date >= @reference_date - INTERVAL '28 days') INTERSECT ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (432851)))",
            "sqlLogicExplanation": "A0028 AND (A0029 OR A0030)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "'Locally advanced unresectable' is a clinical judgment based on imaging and surgical notes, not a standard structured code. Confirming the timing of radiological confirmation also requires reviewing report dates.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0028",
              "A0029",
              "A0030"
            ],
            "atomicCount": 3,
            "internalLogic": "SIMPLE",
            "omopConcepts": [
              {
                "conceptId": 37165616,
                "conceptName": "Locally advanced malignant neoplasm",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "1255249000"
              },
              {
                "conceptId": 432851,
                "conceptName": "Metastatic malignant neoplasm",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "128462008"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|1255249000"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|128462008"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Locally advanced malignant neoplasm",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:1255249000 (domain: Condition)",
                "sourceOmopConceptId": 37165616
              },
              {
                "conceptName": "Metastatic malignant neoplasm",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:128462008 (domain: Condition)",
                "sourceOmopConceptId": 432851
              }
            ],
            "protocolText": "Subject has radiologically confirmed locally advanced unresectable or metastatic disease within 28 days prior to randomization.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Advanced Unresectable Or Metastatic Disease",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0029",
                    "A0030"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Locally advanced unresectable disease OR Metastatic disease"
                },
                {
                  "groupName": "Disease is radiologically confirmed",
                  "clinicalCategory": "diagnostic_confirmation",
                  "atomicIds": [
                    "A0028"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Disease is radiologically confirmed"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Advanced Unresectable Or Metastatic Disease AND Disease is radiologically confirmed"
            }
          },
          {
            "qebId": "QEB_INC_12",
            "originalCriterionId": "INC_12",
            "criterionType": "inclusion",
            "clinicalName": "Radiologically Evaluable Disease per RECIST 1.1",
            "clinicalDescription": "The patient must have tumors that can be seen and evaluated on scans to assess treatment response.",
            "clinicalCategory": "Disease Assessment",
            "funnelStage": "Screening Labs & Imaging Confirmation",
            "funnelStageOrder": 6,
            "combinedSql": "(SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND po.procedure_date >= @reference_date - INTERVAL '3 months'))) UNION (((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND po.procedure_date >= @reference_date - INTERVAL '3 months')) INTERSECT ((SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592))))",
            "sqlLogicExplanation": "A0031 AND IF (A0032 AND A0033) THEN ((A0034 OR A0035))",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "RECIST 1.1 evaluation is a specialized, prospective assessment for a clinical trial and is not recorded as structured data in a standard EHR. It requires expert interpretation of imaging.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0031",
              "A0032",
              "A0033",
              "A0034",
              "A0035"
            ],
            "atomicCount": 5,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 600054592,
                "conceptName": "Radiation Therapy",
                "domain": "Procedure",
                "vocabularyId": "NCIt_Full",
                "conceptCode": "C15313"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Procedure",
                "searchParams": {
                  "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Radiation Therapy",
                "cdiscCode": "CUSTOM",
                "domain": "PR",
                "confidence": 0.7,
                "rationale": "Mapped from OMOP NCIt_Full:C15313 (domain: Procedure)",
                "sourceOmopConceptId": 600054592
              }
            ],
            "protocolText": "Subject has radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects with only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion must either be outside the field of prior radiotherapy or have documented progression following radiation therapy.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Radiologically evaluable disease (measurable and/o...",
                  "clinicalCategory": "diagnostic_confirmation",
                  "atomicIds": [
                    "A0031"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment"
                },
                {
                  "groupName": "Subject has only 1 evaluable lesion",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0032"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Subject has only 1 evaluable lesion"
                },
                {
                  "groupName": "History of radiotherapy",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0033"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "History of radiotherapy"
                },
                {
                  "groupName": "The evaluable lesion is outside the field of prior...",
                  "clinicalCategory": "diagnostic_confirmation",
                  "atomicIds": [
                    "A0034"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "The evaluable lesion is outside the field of prior radiotherapy"
                },
                {
                  "groupName": "The evaluable lesion has documented progression fo...",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0035"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "The evaluable lesion has documented progression following radiation therapy"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Radiologically evaluable disease (measurable and/o..., Subject has only 1 evaluable lesion, History of radiotherapy, and 2 more requirements"
            }
          },
          {
            "qebId": "QEB_INC_13",
            "originalCriterionId": "INC_13",
            "criterionType": "inclusion",
            "clinicalName": "Positive CLDN18.2 Tumor Expression",
            "clinicalDescription": "The patient's tumor must test positive for a specific biomarker called CLDN18.2 at a high level.",
            "clinicalCategory": "Biomarker Status",
            "funnelStage": "Tumor Biomarker Profile (CLDN18.2+/HER2-)",
            "funnelStageOrder": 2,
            "combinedSql": "(SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND m.value_as_number >= 75) INTERSECT (SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "A0036 AND A0037 AND A0038 AND A0039",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "This is a trial-specific central lab test; the result would not be in the historical EHR. Even if tested locally, specific quantitative IHC results (percentage and intensity) are rarely in structured fields.",
            "estimatedEliminationRate": 70.0,
            "isKillerCriterion": true,
            "epidemiologicalEvidence": "Sahin U, et al. FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of CLDN18.2-positive, HER2-negative, advanced gastric or gastro-oesophageal junction cancer. Ann Oncol. 2021.",
            "atomicIds": [
              "A0036",
              "A0037",
              "A0038",
              "A0039"
            ],
            "atomicCount": 4,
            "internalLogic": "AND",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong membranous staining as determined by central IHC testing.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor)."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Cldn18 2 Status",
                  "clinicalCategory": "biomarker",
                  "atomicIds": [
                    "A0036",
                    "A0037",
                    "A0038",
                    "A0039"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Tumor expresses CLDN18.2 OR ... (4 variants)"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Cldn18 2 Status"
            }
          },
          {
            "qebId": "QEB_INC_14",
            "originalCriterionId": "INC_14",
            "criterionType": "inclusion",
            "clinicalName": "Known HER2-Negative Tumor Status",
            "clinicalDescription": "The patient's tumor must be confirmed to be HER2-negative based on prior testing.",
            "clinicalCategory": "Biomarker Status",
            "funnelStage": "Tumor Biomarker Profile (CLDN18.2+/HER2-)",
            "funnelStageOrder": 2,
            "combinedSql": "(SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3019066) AND Result is 'Negative' or equivalent concept for HER2 test) INTERSECT ((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3019066))",
            "sqlLogicExplanation": "A0040 AND (A0041 OR A0042) AND A0043",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Biomarker results are often in unstructured pathology reports. Confirmation requires linking the test result to the correct tumor specimen and interpreting the result.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0040",
              "A0041",
              "A0042",
              "A0043"
            ],
            "atomicCount": 4,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 3019066,
                "conceptName": "HER2 Ag [Presence] in Tissue by Immune stain",
                "domain": "Measurement",
                "vocabularyId": "LOINC",
                "conceptCode": "18474-7"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|62862-8"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "HER2 Ag [Presence] in Tissue by Immune stain",
                "cdiscCode": "CUSTOM",
                "domain": "LB",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP LOINC:18474-7 (domain: Measurement)",
                "sourceOmopConceptId": 3019066
              }
            ],
            "protocolText": "Subject has a known HER2-negative tumor as determined by local or central testing on a gastric or GEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ tumor.)",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Her2 Status",
                  "clinicalCategory": "biomarker",
                  "atomicIds": [
                    "A0040"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "HER2-negative tumor status"
                },
                {
                  "groupName": "Primary Tumor Location",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0041",
                    "A0042"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Gastric tumor OR Gastroesophageal junction (GEJ) tumor"
                },
                {
                  "groupName": "HER2 status determined on a tumor specimen by loca...",
                  "clinicalCategory": "diagnostic_confirmation",
                  "atomicIds": [
                    "A0043"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "HER2 status determined on a tumor specimen by local or central testing"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Her2 Status, Primary Tumor Location, HER2 status determined on a tumor specimen by loca..."
            }
          },
          {
            "qebId": "QEB_INC_15",
            "originalCriterionId": "INC_15",
            "criterionType": "inclusion",
            "clinicalName": "Good ECOG Performance Status (0-1)",
            "clinicalDescription": "The patient must be fully active or have only minor restrictions in their daily activities.",
            "clinicalCategory": "Functional Status",
            "funnelStage": "Clinical Performance & Prognostic Assessment",
            "funnelStageOrder": 3,
            "combinedSql": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND value_as_number >= 0 AND value_as_number <= 1",
            "sqlLogicExplanation": "A0044",
            "queryableStatus": "partially_queryable",
            "nonQueryableReason": "ECOG is a subjective assessment that must be performed at screening. Historical values in the EHR may not be current or accurate for eligibility purposes.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0044"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [
              {
                "conceptId": 36305384,
                "conceptName": "ECOG Performance Status score",
                "domain": "Measurement",
                "vocabularyId": "LOINC",
                "conceptCode": "89247-1"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|89247-1"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "ECOG Performance Status score",
                "cdiscCode": "CUSTOM",
                "domain": "LB",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP LOINC:89247-1 (domain: Measurement)",
                "sourceOmopConceptId": 36305384
              }
            ],
            "protocolText": "Subject has ECOG performance status 0 to 1.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "tumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibil..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "ECOG performance status 0-1",
                  "clinicalCategory": "performance_status",
                  "atomicIds": [
                    "A0044"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "ECOG performance status 0-1"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: ECOG performance status 0-1"
            }
          },
          {
            "qebId": "QEB_INC_16",
            "originalCriterionId": "INC_16",
            "criterionType": "inclusion",
            "clinicalName": "Adequate Life Expectancy (\u2265 12 weeks)",
            "clinicalDescription": "The doctor must expect the patient to live for at least 12 weeks.",
            "clinicalCategory": "Prognosis",
            "funnelStage": "Clinical Performance & Prognostic Assessment",
            "funnelStageOrder": 3,
            "combinedSql": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (3050013) AND value_as_number >= 12",
            "sqlLogicExplanation": "A0045",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "This is a subjective clinical prognosis ('opinion of the investigator') and not a queryable data point.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0045"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [
              {
                "conceptId": 3050013,
                "conceptName": "Life expectancy [OASIS]",
                "domain": "Observation",
                "vocabularyId": "LOINC",
                "conceptCode": "46525-2"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://loinc.org|46525-2"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Life expectancy [OASIS]",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP LOINC:46525-2 (domain: Observation)",
                "sourceOmopConceptId": 3050013
              }
            ],
            "protocolText": "Subject has predicted life expectancy \u2265 12 weeks in the opinion of the investigator.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "Physical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibility. \na...."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Predicted life expectancy \u2265 12 weeks in the opinio...",
                  "clinicalCategory": "performance_status",
                  "atomicIds": [
                    "A0045"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Predicted life expectancy \u2265 12 weeks in the opinion of the investigator"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Predicted life expectancy \u2265 12 weeks in the opinio..."
            }
          },
          {
            "qebId": "QEB_INC_17",
            "originalCriterionId": "INC_17",
            "criterionType": "inclusion",
            "clinicalName": "Adequate Organ Function via Recent Labs",
            "clinicalDescription": "The patient must have acceptable lab results for organ function from tests taken within 14 days of starting the study.",
            "clinicalCategory": "Laboratory Values",
            "funnelStage": "Screening Labs & Imaging Confirmation",
            "funnelStageOrder": 6,
            "combinedSql": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
            "sqlLogicExplanation": "A0046",
            "queryableStatus": "partially_queryable",
            "nonQueryableReason": "The strict timing requirement ('within 14 days') often necessitates new labs at screening. A query of historical data may not find labs within the required window.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0046"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject must meet all of the following criteria based on the centrally or locally analyzed laboratory tests collected within 14 days prior to randomization. In the case of multiple sample collections within this period, the most recent sample collection with available results should be used to determine eligibility.",
            "provenance": {
              "pageNumber": 25,
              "sectionId": null,
              "textSnippet": "16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibility. \na. Hemoglobin (Hgb) \u2265 9 g/dL. Subjects requiring transfusions are eligible if they..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Required laboratory tests for eligibility assessme...",
                  "clinicalCategory": "diagnostic_confirmation",
                  "atomicIds": [
                    "A0046"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Required laboratory tests for eligibility assessment collected"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must meet: Required laboratory tests for eligibility assessme..."
            }
          },
          {
            "qebId": "QEB_EXC_1",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "clinicalName": "No Prior Systemic Therapy for Advanced Disease",
            "clinicalDescription": "Patients must not have received prior chemotherapy for their advanced or metastatic stomach cancer.",
            "clinicalCategory": "Prior Therapy",
            "funnelStage": "Primary Diagnosis & Treatment Line",
            "funnelStageOrder": 1,
            "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)))) UNION (((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847))) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847))))) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE))))",
            "sqlLogicExplanation": "A0047 AND IF ((A0048 OR A0049 OR A0050)) THEN (NOT (A0051)) AND IF (A0052) THEN (NOT (A0053))",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Distinguishing the intent of prior therapy (adjuvant vs. for advanced disease) requires clinical context often found only in unstructured notes, not just medication lists.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0047",
              "A0048",
              "A0049",
              "A0050",
              "A0051",
              "A0052",
              "A0053"
            ],
            "atomicCount": 7,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 37165616,
                "conceptName": "Locally advanced malignant neoplasm",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "1255249000"
              },
              {
                "conceptId": 4329847,
                "conceptName": "Myocardial infarction",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "22298006"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|1255249000"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|22298006,I21.9"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Locally advanced malignant neoplasm",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:1255249000 (domain: Condition)",
                "sourceOmopConceptId": 37165616
              },
              {
                "conceptName": "Myocardial infarction",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
                "sourceOmopConceptId": 4329847
              }
            ],
            "protocolText": "Subject has received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo-adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as long as it was completed at least 6 months prior to randomization. Subject may have received treatment with herbal medications that have known antitumor activity > 28 days prior to randomization.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Prior Systemic Therapy",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0048",
                    "A0049",
                    "A0050"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received neo-adjuvant or adjuvant chemotherapy OR Received immunotherapy OR Received other systemic anticancer therapies"
                },
                {
                  "groupName": "Received prior systemic chemotherapy for locally a...",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0047"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma"
                },
                {
                  "groupName": "Completion of neo-adjuvant/adjuvant chemotherapy, ...",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0051"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy"
                },
                {
                  "groupName": "Received treatment with herbal medications that ha...",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0052"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Received treatment with herbal medications that have known antitumor activity"
                },
                {
                  "groupName": "Completion of treatment with herbal medications wi...",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0053"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Completion of treatment with herbal medications with known antitumor activity"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Prior Systemic Therapy, Received prior systemic chemotherapy for locally a..., Completion of neo-adjuvant/adjuvant chemotherapy, ..., and 2 more requirements"
            }
          },
          {
            "qebId": "QEB_EXC_2",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "clinicalName": "Recent Radiotherapy with Unresolved Toxicity",
            "clinicalDescription": "Patients who had radiation therapy for their advanced cancer within the last 14 days and still have side effects are excluded.",
            "clinicalCategory": "Prior Therapy",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "(SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
            "sqlLogicExplanation": "A0054 AND (A0055 OR A0056) AND (A0057 OR A0058) AND NOT (A0059)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Assessing recovery from toxicity is a clinical judgment based on chart review or patient examination and is not captured in structured EHR data.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0054",
              "A0055",
              "A0056",
              "A0057",
              "A0058",
              "A0059"
            ],
            "atomicCount": 6,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 196044,
                "conceptName": "Primary malignant neoplasm of stomach",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "372014001"
              },
              {
                "conceptId": 37165616,
                "conceptName": "Locally advanced malignant neoplasm",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "1255249000"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|372014001,C16.9"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|1255249000"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Primary malignant neoplasm of stomach",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:372014001 (domain: Condition)",
                "sourceOmopConceptId": 196044
              },
              {
                "conceptName": "Locally advanced malignant neoplasm",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:1255249000 (domain: Condition)",
                "sourceOmopConceptId": 37165616
              }
            ],
            "protocolText": "Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related toxicity.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Gastric Gej Adenocarcinoma",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0055",
                    "A0056"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Diagnosis of gastric adenocarcinoma OR Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma"
                },
                {
                  "groupName": "Disease Stage Unresectable Metastatic",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0057",
                    "A0058"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Disease is locally advanced unresectable OR Disease is metastatic"
                },
                {
                  "groupName": "Received radiotherapy",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0054"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received radiotherapy"
                },
                {
                  "groupName": "Recovered from radiotherapy-related toxicity",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0059"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Recovered from radiotherapy-related toxicity"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Gastric Gej Adenocarcinoma, Disease Stage Unresectable Metastatic, Received radiotherapy, and 1 more requirements"
            }
          },
          {
            "qebId": "QEB_EXC_3",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "clinicalName": "Recent Systemic Immunosuppressive Therapy",
            "clinicalDescription": "Patients cannot have recently received medications that suppress the immune system, such as high-dose steroids.",
            "clinicalCategory": "Concomitant Medications",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847))) INTERSECT ((SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)))",
            "sqlLogicExplanation": "(A0060 OR A0061) AND (A0062 OR A0063 OR A0064 OR A0065)",
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "The reason/intent for corticosteroid use (e.g., physiologic replacement vs. immunosuppression) is not available in structured medication data and requires chart review.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0060",
              "A0061",
              "A0062",
              "A0063",
              "A0064",
              "A0065"
            ],
            "atomicCount": 6,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 4329847,
                "conceptName": "Myocardial infarction",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "22298006"
              },
              {
                "conceptId": 1243048,
                "conceptName": "Systemic corticosteroid therapy",
                "domain": "Procedure",
                "vocabularyId": "SNOMED",
                "conceptCode": "1290388005"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|22298006,I21.9"
                },
                "description": null
              },
              {
                "resourceType": "MedicationStatement",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|1290388005"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Myocardial infarction",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
                "sourceOmopConceptId": 4329847
              },
              {
                "conceptName": "Systemic corticosteroid therapy",
                "cdiscCode": "CUSTOM",
                "domain": "PR",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:1290388005 (domain: Procedure)",
                "sourceOmopConceptId": 1243048
              }
            ],
            "protocolText": "Subject has received systemic immunosuppressive therapy, including systemic corticosteroids within 14 days prior to randomization. Subjects using a physiologic replacement dose of hydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 mg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Systemic Immunosuppression",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0060",
                    "A0061"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received systemic immunosuppressive therapy OR Received systemic corticosteroids"
                },
                {
                  "groupName": "Physiologic Steroid Dose",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0062",
                    "A0063"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received hydrocortisone at a physiologic replacement dose up to 30 mg/day OR Received prednisone at a physiologic replacement dose up to 10 mg/day"
                },
                {
                  "groupName": "Received a single dose of systemic corticosteroids",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0064"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received a single dose of systemic corticosteroids"
                },
                {
                  "groupName": "Received systemic corticosteroids as premedication...",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0065"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Received systemic corticosteroids as premedication for radiologic imaging contrast use"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Systemic Immunosuppression, Physiologic Steroid Dose, Received a single dose of systemic corticosteroids, and 1 more requirements"
            }
          },
          {
            "qebId": "QEB_EXC_4",
            "originalCriterionId": "EXC_4",
            "criterionType": "exclusion",
            "clinicalName": "Prior Investigational Agent or Device",
            "clinicalDescription": "Patients cannot have participated in another clinical trial with an investigational drug or device within the last 28 days.",
            "clinicalCategory": "Prior Therapy",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "(SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)) UNION (SELECT DISTINCT de.person_id\nFROM device_exposure de\nWHERE de.device_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "(A0066 OR A0067)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Participation in other clinical trials is not a standard structured data element in the EHR and relies on patient self-report.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0066",
              "A0067"
            ],
            "atomicCount": 2,
            "internalLogic": "SIMPLE",
            "omopConcepts": [
              {
                "conceptId": 600058216,
                "conceptName": "Other Investigational Agent",
                "domain": "Observation",
                "vocabularyId": "NCIt_Full",
                "conceptCode": "C156875"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "MedicationStatement",
                "searchParams": {
                  "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Other Investigational Agent",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.7,
                "rationale": "Mapped from OMOP NCIt_Full:C156875 (domain: Observation)",
                "sourceOmopConceptId": 600058216
              }
            ],
            "protocolText": "Subject has received other investigational agents or devices within 28 days prior to randomization.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.\n4. Subject has received other investigational agents or devices within 28 days prior to \nrandomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Investigational Product Exposure",
                  "clinicalCategory": "prior_therapy",
                  "atomicIds": [
                    "A0066",
                    "A0067"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Received other investigational agents OR Received other investigational devices"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Investigational Product Exposure"
            }
          },
          {
            "qebId": "QEB_EXC_5",
            "originalCriterionId": "EXC_5",
            "criterionType": "exclusion",
            "clinicalName": "Known Hypersensitivity to Monoclonal Antibodies",
            "clinicalDescription": "Patients with a known severe allergy to the study drug zolbetuximab or similar antibody-based drugs are excluded.",
            "clinicalCategory": "Medical History / Contraindications",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "(A0068 OR A0069 OR A0070 OR A0071)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Allergy data can be incomplete or non-specific. A broad class allergy like 'monoclonal antibodies' is unlikely to be coded structurally; review of notes would be needed.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0068",
              "A0069",
              "A0070",
              "A0071"
            ],
            "atomicCount": 4,
            "internalLogic": "OR",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab or other monoclonal antibodies, including humanized or chimeric antibodies.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Zolbetuximab Hypersensitivity",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0068"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab"
                },
                {
                  "groupName": "Mab Hypersensitivity",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0069",
                    "A0070",
                    "A0071"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Prior severe allergic reaction or intolerance to other monoclonal antibodies OR Prior severe allergic reaction or intolerance to humanized antibodies OR Prior severe allergic reaction or intolerance to chimeric antibodies"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Zolbetuximab Hypersensitivity OR Mab Hypersensitivity"
            }
          },
          {
            "qebId": "QEB_EXC_6",
            "originalCriterionId": "EXC_6",
            "criterionType": "exclusion",
            "clinicalName": "Known Hypersensitivity to Study Treatment Components",
            "clinicalDescription": "Patients with a known allergy or intolerance to any ingredient in the study treatments are not eligible.",
            "clinicalCategory": "Medical History / Contraindications",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "(A0072 OR A0073 OR A0074 OR A0075)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Allergy data can be incomplete or documented as free text in clinical notes rather than in structured fields.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0072",
              "A0073",
              "A0074",
              "A0075"
            ],
            "atomicCount": 4,
            "internalLogic": "OR",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to any component of study treatment.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Drug Allergy Intolerance Contraindication",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0072",
                    "A0073",
                    "A0074",
                    "A0075"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Known immediate hypersensitivity to any component of study treatment OR ... (4 variants)"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Drug Allergy Intolerance Contraindication"
            }
          },
          {
            "qebId": "QEB_EXC_7",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "clinicalName": "Known Hypersensitivity to mFOLFOX6 Components",
            "clinicalDescription": "Patients with a known severe allergy to any of the drugs in the mFOLFOX6 chemotherapy regimen are excluded.",
            "clinicalCategory": "Medical History / Contraindications",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629))",
            "sqlLogicExplanation": "(A0076 OR A0077 OR A0078 OR A0079 OR A0080 OR A0081)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Allergy data can be incomplete or documented as free text in clinical notes rather than in structured fields.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0076",
              "A0077",
              "A0078",
              "A0079",
              "A0080",
              "A0081"
            ],
            "atomicCount": 6,
            "internalLogic": "OR",
            "omopConcepts": [
              {
                "conceptId": 4273629,
                "conceptName": "Chemotherapy",
                "domain": "Procedure",
                "vocabularyId": "SNOMED",
                "conceptCode": "367336001"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Procedure",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|367336001"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Chemotherapy",
                "cdiscCode": "CUSTOM",
                "domain": "PR",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:367336001 (domain: Procedure)",
                "sourceOmopConceptId": 4273629
              }
            ],
            "protocolText": "Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)"
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Mfolfox6 Leucovorin Contraindication",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0076",
                    "A0079"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Prior severe allergic reaction to Leucovorin OR Prior intolerance to Leucovorin"
                },
                {
                  "groupName": "Mfolfox6 Fluorouracil Contraindication",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0077",
                    "A0080"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Prior severe allergic reaction to Fluorouracil OR Prior intolerance to Fluorouracil"
                },
                {
                  "groupName": "Mfolfox6 Oxaliplatin Contraindication",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0078",
                    "A0081"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Prior severe allergic reaction to Oxaliplatin OR Prior intolerance to Oxaliplatin"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Mfolfox6 Leucovorin Contraindication OR Mfolfox6 Fluorouracil Contraindication OR Mfolfox6 Oxaliplatin Contraindication"
            }
          },
          {
            "qebId": "QEB_EXC_8",
            "originalCriterionId": "EXC_8",
            "criterionType": "exclusion",
            "clinicalName": "Known Dihydropyrimidine Dehydrogenase (DPD) Deficiency",
            "clinicalDescription": "Patients with a known genetic condition called DPD deficiency, which affects how they process certain chemotherapy, are excluded.",
            "clinicalCategory": "Medical History / Contraindications",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
            "sqlLogicExplanation": "A0082",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Most patients will not have been pre-emptively tested for DPD deficiency. A 'known' deficiency is rare and often triggers prospective screening.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0082"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has known dihydropyrimidine dehydrogenase (DPD) deficiency. (NOTE: Screening for DPD deficiency should be conducted per local requirements.)",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Known dihydropyrimidine dehydrogenase (DPD) defici...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0082"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Known dihydropyrimidine dehydrogenase (DPD) deficiency"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Known dihydropyrimidine dehydrogenase (DPD) defici..."
            }
          },
          {
            "qebId": "QEB_EXC_9",
            "originalCriterionId": "EXC_9",
            "criterionType": "exclusion",
            "clinicalName": "Symptomatic Gastric Outlet Obstruction",
            "clinicalDescription": "Patients who have a blockage at the stomach exit that causes persistent vomiting are not eligible.",
            "clinicalCategory": "Disease-Related Complications",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION ((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
            "sqlLogicExplanation": "(A0083 OR A0084 AND A0085)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "The severity and symptomatic nature ('persistent/recurrent vomiting') are clinical details found in unstructured notes, not in the diagnosis code itself.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0083",
              "A0084",
              "A0085"
            ],
            "atomicCount": 3,
            "internalLogic": "COMPLEX",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with persistent/recurrent vomiting.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Gastric Outlet Syndrome",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0083",
                    "A0084"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Complete gastric outlet syndrome OR Partial gastric outlet syndrome"
                },
                {
                  "groupName": "Persistent or recurrent vomiting",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0085"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Persistent or recurrent vomiting"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Gastric Outlet Syndrome, Persistent or recurrent vomiting"
            }
          },
          {
            "qebId": "QEB_EXC_10",
            "originalCriterionId": "EXC_10",
            "criterionType": "exclusion",
            "clinicalName": "Significant Gastric Bleeding or Ulcers",
            "clinicalDescription": "Patients with significant stomach bleeding or untreated ulcers are excluded based on the doctor's judgment.",
            "clinicalCategory": "Disease-Related Complications",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "(A0086 OR A0087)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "Relies entirely on subjective 'investigator judgment,' which cannot be queried from structured or unstructured data.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0086",
              "A0087"
            ],
            "atomicCount": 2,
            "internalLogic": "OR",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Per investigator judgment, subject has significant gastric bleeding and/or untreated gastric ulcers that would exclude the subject from participation per investigator judgment.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted p..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Significant gastric bleeding",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0086"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Significant gastric bleeding"
                },
                {
                  "groupName": "Untreated gastric ulcers",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0087"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Untreated gastric ulcers"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Significant gastric bleeding OR Untreated gastric ulcers"
            }
          },
          {
            "qebId": "QEB_EXC_11",
            "originalCriterionId": "EXC_11",
            "criterionType": "exclusion",
            "clinicalName": "Active HIV, Hepatitis B, or Hepatitis C Infection",
            "clinicalDescription": "Patients with a known HIV infection or an active Hepatitis B or C infection are not eligible.",
            "clinicalCategory": "Comorbid Conditions / Infections",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439727)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439674)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (198964))",
            "sqlLogicExplanation": "(A0088 OR A0089 OR A0090)",
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": null,
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0088",
              "A0089",
              "A0090"
            ],
            "atomicCount": 3,
            "internalLogic": "OR",
            "omopConcepts": [
              {
                "conceptId": 439727,
                "conceptName": "Human immunodeficiency virus infection",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "86406008"
              },
              {
                "conceptId": 439674,
                "conceptName": "Chronic viral hepatitis B without delta-agent",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "186639003"
              },
              {
                "conceptId": 198964,
                "conceptName": "Chronic hepatitis C",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "128302006"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|86406008,B20"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|186639003,B18.1"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|128302006,B18.2"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Human immunodeficiency virus infection",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:86406008 (domain: Condition)",
                "sourceOmopConceptId": 439727
              },
              {
                "conceptName": "Chronic viral hepatitis B without delta-agent",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:186639003 (domain: Condition)",
                "sourceOmopConceptId": 439674
              },
              {
                "conceptName": "Chronic hepatitis C",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:128302006 (domain: Condition)",
                "sourceOmopConceptId": 198964
              }
            ],
            "protocolText": "Subject has a known history of a positive test for human immunodeficiency virus (HIV) infection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for these infections should be conducted per local requirements.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ..."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Viral Infection Exclusion",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0088",
                    "A0089",
                    "A0090"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "History of positive test for Human Immunodeficiency Virus (HIV) infection OR Active Hepatitis B infection (positive HBsAg) OR Active Hepatitis C infection"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Viral Infection Exclusion"
            }
          },
          {
            "qebId": "QEB_EXC_12",
            "originalCriterionId": "EXC_12",
            "criterionType": "exclusion",
            "clinicalName": "Active Autoimmune Disease Requiring Systemic Therapy",
            "clinicalDescription": "Patients with an active autoimmune disease that needed systemic treatment in the last 3 months are excluded.",
            "clinicalCategory": "Comorbid Conditions",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (434621)) INTERSECT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847))",
            "sqlLogicExplanation": "A0091 AND A0092",
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "Determining if a disease was 'active' and if a specific therapy was for that disease within a specific timeframe requires clinical context from notes.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0091",
              "A0092"
            ],
            "atomicCount": 2,
            "internalLogic": "AND",
            "omopConcepts": [
              {
                "conceptId": 434621,
                "conceptName": "Autoimmune disease",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "85828009"
              },
              {
                "conceptId": 4329847,
                "conceptName": "Myocardial infarction",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "22298006"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|85828009"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|22298006,I21.9"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Autoimmune disease",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:85828009 (domain: Condition)",
                "sourceOmopConceptId": 434621
              },
              {
                "conceptName": "Myocardial infarction",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
                "sourceOmopConceptId": 4329847
              }
            ],
            "protocolText": "Subject has an active autoimmune disease that has required systemic treatment within the past 3 months prior to randomization.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "c. Subjects treated with HCV with undetectable viral load results are eligible.\n12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Active autoimmune disease",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0091"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Active autoimmune disease"
                },
                {
                  "groupName": "Required systemic treatment for autoimmune disease",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0092"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Required systemic treatment for autoimmune disease"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Active autoimmune disease AND Required systemic treatment for autoimmune disease"
            }
          },
          {
            "qebId": "QEB_EXC_13",
            "originalCriterionId": "EXC_13",
            "criterionType": "exclusion",
            "clinicalName": "Active Unresolved Systemic Infection",
            "clinicalDescription": "Patients with an active infection requiring IV or oral antibiotics that has not resolved are excluded.",
            "clinicalCategory": "Comorbid Conditions / Infections",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (432250)) INTERSECT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
            "sqlLogicExplanation": "A0093 AND A0094 AND NOT (A0095)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "The status of an infection ('active,' 'not completely resolved') is a point-in-time clinical assessment, not a static data point in the EHR.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0093",
              "A0094",
              "A0095"
            ],
            "atomicCount": 3,
            "internalLogic": "AND",
            "omopConcepts": [
              {
                "conceptId": 432250,
                "conceptName": "Infectious disease",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "40733004"
              },
              {
                "conceptId": 4329847,
                "conceptName": "Myocardial infarction",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "22298006"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|40733004"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|22298006,I21.9"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Infectious disease",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:40733004 (domain: Condition)",
                "sourceOmopConceptId": 432250
              },
              {
                "conceptName": "Myocardial infarction",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
                "sourceOmopConceptId": 4329847
              }
            ],
            "protocolText": "Subject has active infection requiring systemic therapy that has not completely resolved within 7 days prior to randomization.",
            "provenance": {
              "pageNumber": 26,
              "sectionId": null,
              "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Active infection",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0093"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Active infection"
                },
                {
                  "groupName": "Requires systemic therapy for infection",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0094"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Requires systemic therapy for infection"
                },
                {
                  "groupName": "Infection has completely resolved",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0095"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Infection has completely resolved"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Active infection AND Requires systemic therapy for infection AND Infection has completely resolved"
            }
          },
          {
            "qebId": "QEB_EXC_14",
            "originalCriterionId": "EXC_14",
            "criterionType": "exclusion",
            "clinicalName": "Significant Cardiovascular Disease",
            "clinicalDescription": "Patients with certain significant heart or blood vessel diseases are not eligible for the study.",
            "clinicalCategory": "Comorbid Conditions / Cardiac",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
            "sqlLogicExplanation": "A0096",
            "queryableStatus": "partially_queryable",
            "nonQueryableReason": "The definition of 'significant' and confirming the timing and stability of cardiac conditions often requires review of clinical notes and cardiology reports.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0096"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has significant cardiovascular disease, including any of the following:",
            "provenance": {
              "pageNumber": 65,
              "sectionId": null,
              "textSnippet": "13. Subject has active infection requiring systemic therapy that has not completely \nresolved within 7 days prior to randomization.\n14. Subject has significant cardiovascular disease, including any of the following:"
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Significant Cardiovascular Disease",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0096"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Significant cardiovascular disease"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Significant Cardiovascular Disease"
            }
          },
          {
            "qebId": "QEB_EXC_15",
            "originalCriterionId": "EXC_15",
            "criterionType": "exclusion",
            "clinicalName": "History of CNS Metastases or Carcinomatous Meningitis",
            "clinicalDescription": "Patients whose stomach cancer has spread to the brain or the lining of the brain are excluded.",
            "clinicalCategory": "Disease Stage / Extent",
            "funnelStage": "Clinical Performance & Prognostic Assessment",
            "funnelStageOrder": 3,
            "combinedSql": "((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT ((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 600131150))",
            "sqlLogicExplanation": "(A0097 OR A0098) AND (A0099 OR A0100)",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": null,
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0097",
              "A0098",
              "A0099",
              "A0100"
            ],
            "atomicCount": 4,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 196044,
                "conceptName": "Primary malignant neoplasm of stomach",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "372014001"
              },
              {
                "conceptId": 600131150,
                "conceptName": "Meningeal Carcinomatosis",
                "domain": "Observation",
                "vocabularyId": "NCIt_Full",
                "conceptCode": "C27383"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|372014001,C16.9"
                },
                "description": null
              },
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://ncithesaurus-stage.nci.nih.gov|C27383"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Primary malignant neoplasm of stomach",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:372014001 (domain: Condition)",
                "sourceOmopConceptId": 196044
              },
              {
                "conceptName": "Meningeal Carcinomatosis",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.7,
                "rationale": "Mapped from OMOP NCIt_Full:C27383 (domain: Observation)",
                "sourceOmopConceptId": 600131150
              }
            ],
            "protocolText": "Subject has history of central nervous system metastases and/or carcinomatous meningitis from gastric/GEJ cancer.",
            "provenance": {
              "pageNumber": 66,
              "sectionId": null,
              "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Gastric Gej Cancer",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0097",
                    "A0098"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "History of gastric cancer OR History of gastroesophageal junction (GEJ) cancer"
                },
                {
                  "groupName": "Cns Involvement",
                  "clinicalCategory": "disease_indication",
                  "atomicIds": [
                    "A0099",
                    "A0100"
                  ],
                  "queryableStatus": "fully_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "History of central nervous system metastases OR History of carcinomatous meningitis"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Gastric Gej Cancer, Cns Involvement"
            }
          },
          {
            "qebId": "QEB_EXC_16",
            "originalCriterionId": "EXC_16",
            "criterionType": "exclusion",
            "clinicalName": "Pre-existing Significant Peripheral Neuropathy (> Grade 1)",
            "clinicalDescription": "Patients who already have more than mild numbness or tingling in their hands or feet are not eligible.",
            "clinicalCategory": "Comorbid Conditions / Neurologic",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4117779)) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))))",
            "sqlLogicExplanation": "A0101 AND NOT (A0102) AND NOT (A0103)",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "Neuropathy grading (e.g., CTCAE Grade > 1) is a subjective clinical assessment based on symptoms and physical exam, not a structured EHR data point.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0101",
              "A0102",
              "A0103"
            ],
            "atomicCount": 3,
            "internalLogic": "COMPLEX",
            "omopConcepts": [
              {
                "conceptId": 4117779,
                "conceptName": "Peripheral nerve disease",
                "domain": "Condition",
                "vocabularyId": "SNOMED",
                "conceptCode": "302226006"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Condition",
                "searchParams": {
                  "query": "code=http://snomed.info/sct|302226006,G62.9"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Peripheral nerve disease",
                "cdiscCode": "CUSTOM",
                "domain": "MH",
                "confidence": 0.85,
                "rationale": "Mapped from OMOP SNOMED:302226006 (domain: Condition)",
                "sourceOmopConceptId": 4117779
              }
            ],
            "protocolText": "Subject has known peripheral sensory neuropathy > grade 1 unless the absence of deep tendon reflexes is the sole neurological abnormality.",
            "provenance": {
              "pageNumber": 66,
              "sectionId": null,
              "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Peripheral Neuropathy",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0101"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Peripheral sensory neuropathy grade > 1"
                },
                {
                  "groupName": "Deep tendon reflexes present",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0102"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Deep tendon reflexes present"
                },
                {
                  "groupName": "Other neurological abnormality present",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0103"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Other neurological abnormality present"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Peripheral Neuropathy, Deep tendon reflexes present, Other neurological abnormality present"
            }
          },
          {
            "qebId": "QEB_EXC_17",
            "originalCriterionId": "EXC_17",
            "criterionType": "exclusion",
            "clinicalName": "Major Surgery Within 28 Days",
            "clinicalDescription": "Patients who have had a major surgery within the last 28 days are not eligible.",
            "clinicalCategory": "Prior Procedures",
            "funnelStage": "Recent Interventions & Active Conditions",
            "funnelStageOrder": 5,
            "combinedSql": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
            "sqlLogicExplanation": "A0104",
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "The definition of 'major' surgery can be subjective and may require review of procedure notes to confirm.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0104"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has had a major surgical procedure \u2264 28 days prior to randomization.",
            "provenance": {
              "pageNumber": 66,
              "sectionId": null,
              "textSnippet": "deep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Had a major surgical procedure",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0104"
                  ],
                  "queryableStatus": "partially_queryable",
                  "treatmentImplication": null,
                  "plainEnglish": "Had a major surgical procedure"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Had a major surgical procedure"
            }
          },
          {
            "qebId": "QEB_EXC_18",
            "originalCriterionId": "EXC_18",
            "criterionType": "exclusion",
            "clinicalName": "Psychiatric or Social Condition Impeding Compliance",
            "clinicalDescription": "Patients with a mental health or social situation that would make it difficult to follow the study requirements are excluded.",
            "clinicalCategory": "Subject Compliance",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)",
            "sqlLogicExplanation": "(A0105 OR A0106)",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "Relies entirely on subjective 'investigator judgment,' which cannot be queried.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0105",
              "A0106"
            ],
            "atomicCount": 2,
            "internalLogic": "OR",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has psychiatric illness or social situations that would preclude study compliance, per investigator judgment.",
            "provenance": {
              "pageNumber": 66,
              "sectionId": null,
              "textSnippet": "a. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Psychiatric illness that would preclude study comp...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0105"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Psychiatric illness that would preclude study compliance per investigator judgment"
                },
                {
                  "groupName": "Social situations that would preclude study compli...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0106"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Social situations that would preclude study compliance per investigator judgment"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Psychiatric illness that would preclude study comp... OR Social situations that would preclude study compli..."
            }
          },
          {
            "qebId": "QEB_EXC_19",
            "originalCriterionId": "EXC_19",
            "criterionType": "exclusion",
            "clinicalName": "Concurrent Malignancy Requiring Active Treatment",
            "clinicalDescription": "Patients who have another type of cancer that currently requires treatment are not eligible.",
            "clinicalCategory": "Medical History / Comorbid Conditions",
            "funnelStage": "Comprehensive Medical History & Contraindications",
            "funnelStageOrder": 4,
            "combinedSql": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
            "sqlLogicExplanation": "A0107",
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "Determining if treatment for another malignancy is 'required' is a clinical judgment that needs context from chart review.",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0107"
            ],
            "atomicCount": 1,
            "internalLogic": "SIMPLE",
            "omopConcepts": [
              {
                "conceptId": 600055953,
                "conceptName": "Prior Invasive Malignancy",
                "domain": "Observation",
                "vocabularyId": "NCIt_Full",
                "conceptCode": "C154619"
              }
            ],
            "fhirResources": [
              {
                "resourceType": "Observation",
                "searchParams": {
                  "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619"
                },
                "description": null
              }
            ],
            "biomedicalConcepts": [
              {
                "conceptName": "Prior Invasive Malignancy",
                "cdiscCode": "CUSTOM",
                "domain": "VS",
                "confidence": 0.7,
                "rationale": "Mapped from OMOP NCIt_Full:C154619 (domain: Observation)",
                "sourceOmopConceptId": 600055953
              }
            ],
            "protocolText": "Subject has another malignancy for which treatment is required per investigator\u2019s clinical judgment.",
            "provenance": {
              "pageNumber": 66,
              "sectionId": null,
              "textSnippet": "18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Another malignancy for which treatment is required",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0107"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Another malignancy for which treatment is required"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Another malignancy for which treatment is required"
            }
          },
          {
            "qebId": "QEB_EXC_20",
            "originalCriterionId": "EXC_20",
            "criterionType": "exclusion",
            "clinicalName": "Other Conditions Affecting Safety or Compliance",
            "clinicalDescription": "Patients with any other medical condition that the study doctor believes would make participation unsafe are excluded.",
            "clinicalCategory": "General Health Status",
            "funnelStage": "Informed Consent & Study Commitments",
            "funnelStageOrder": 7,
            "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
            "sqlLogicExplanation": "(A0108 OR A0109 OR A0110)",
            "queryableStatus": "requires_manual",
            "nonQueryableReason": "This is a catch-all criterion that relies entirely on the subjective 'opinion of the investigator.'",
            "estimatedEliminationRate": null,
            "isKillerCriterion": false,
            "epidemiologicalEvidence": null,
            "atomicIds": [
              "A0108",
              "A0109",
              "A0110"
            ],
            "atomicCount": 3,
            "internalLogic": "OR",
            "omopConcepts": [],
            "fhirResources": [],
            "biomedicalConcepts": [],
            "protocolText": "Subject has any concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study, which places the subject at undue risk or complicates the interpretation of data in the opinion of the investigator.",
            "provenance": {
              "pageNumber": 66,
              "sectionId": null,
              "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator."
            },
            "clinicalSummary": {
              "conceptGroups": [
                {
                  "groupName": "Concurrent disease, infection or comorbid conditio...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0108"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study"
                },
                {
                  "groupName": "Concurrent disease, infection or comorbid conditio...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0109"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Concurrent disease, infection or comorbid condition that places the subject at undue risk"
                },
                {
                  "groupName": "Concurrent disease, infection or comorbid conditio...",
                  "clinicalCategory": "safety_exclusion",
                  "atomicIds": [
                    "A0110"
                  ],
                  "queryableStatus": "requires_manual",
                  "treatmentImplication": null,
                  "plainEnglish": "Concurrent disease, infection or comorbid condition that complicates the interpretation of data"
                }
              ],
              "screeningOnlyRequirements": [],
              "clinicalLogicSummary": "Patient must NOT have: Concurrent disease, infection or comorbid conditio... OR Concurrent disease, infection or comorbid conditio... OR Concurrent disease, infection or comorbid conditio..."
            }
          }
        ],
        "executionGuide": {
          "recommendedOrder": [
            "QEB_INC_10",
            "QEB_INC_2",
            "QEB_INC_11",
            "QEB_EXC_1",
            "QEB_INC_13",
            "QEB_INC_14",
            "QEB_INC_15",
            "QEB_INC_16",
            "QEB_EXC_15",
            "QEB_EXC_5",
            "QEB_EXC_6",
            "QEB_EXC_7",
            "QEB_EXC_8",
            "QEB_EXC_11",
            "QEB_EXC_12",
            "QEB_EXC_14",
            "QEB_EXC_16",
            "QEB_EXC_19",
            "QEB_EXC_2",
            "QEB_EXC_3",
            "QEB_EXC_4",
            "QEB_EXC_9",
            "QEB_EXC_10",
            "QEB_EXC_13",
            "QEB_EXC_17",
            "QEB_INC_12",
            "QEB_INC_17",
            "QEB_INC_1",
            "QEB_INC_3",
            "QEB_INC_4",
            "QEB_INC_5",
            "QEB_INC_6",
            "QEB_INC_7",
            "QEB_INC_8",
            "QEB_INC_9",
            "QEB_EXC_18",
            "QEB_EXC_20"
          ],
          "killerCriteria": [
            "QEB_INC_10",
            "QEB_INC_13"
          ],
          "manualReviewRequired": [
            "QEB_INC_1",
            "QEB_INC_4",
            "QEB_INC_12",
            "QEB_INC_16",
            "QEB_EXC_16",
            "QEB_EXC_18",
            "QEB_EXC_20"
          ],
          "executionNotes": "Execute criteria in recommended order for optimal patient elimination. Killer criteria should be prioritized as they eliminate the most patients."
        },
        "atomicCriteria": [
          {
            "atomicId": "A0001",
            "originalCriterionId": "INC_1",
            "criterionType": "inclusion",
            "atomicText": "IRB/IEC approved written informed consent and privacy language obtained from subject or legally authorized representative",
            "normalizedText": "IRB/IEC approved written informed consent and privacy language obtained from subject or legally authorized representative",
            "category": "diagnostic_confirmation",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_1_1a",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 1
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "Inclusion/Exclusion Criteria:\nInclusion Criteria: \nWaivers to the inclusion criteria will NOT be allowed.\nGeneral Criteria:\n1. Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written \ninformed consent and privacy language as per national regulations (e.g., Health Insurance \nPortability and Accountability Act [HIPAA] Authorization for US sites) must be obtained from \nthe subject or legally authorized representative (if applicable) prior to any study-related \nproced...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "screening_only",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 1.0,
              "reasoning": "The criterion explicitly requires obtaining 'informed consent', which is a decision made by the patient or their representative at the time of enrollment. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0001",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The criterion explicitly requires obtaining 'informed consent', which is a decision made by the patient or their representative at the time of enrollment."
              }
            }
          },
          {
            "atomicId": "A0002",
            "originalCriterionId": "INC_2",
            "criterionType": "inclusion",
            "atomicText": "Age >= 18 years at the time of signing informed consent",
            "normalizedText": "Age >= 18 years at the time of signing informed consent",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 20.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                4265453
              ],
              "conceptNames": [
                "Age"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "397669002"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
              "sqlExecutable": true,
              "valueConstraint": "value_as_number >= 18"
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "30525-0",
                  "display": "Age"
                }
              ],
              "searchParams": "code=http://loinc.org|30525-0",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_2_1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 2
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "the subject or legally authorized representative (if applicable) prior to any study-related \nprocedures.\n2. Subject is considered an adult (e.g., \u2265 18 years of age in the US) according to local regulation\nat the time of signing the informed consent.\n3. Subject agrees not to participate in another interventional study while on study treatment.",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 1.0,
              "reasoning": "Age is a standard demographic field found in structured EHR data (e.g., patient demographics table). Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0002",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Age is a standard demographic field found in structured EHR data (e.g., patient demographics table)."
              }
            }
          },
          {
            "atomicId": "A0003",
            "originalCriterionId": "INC_3",
            "criterionType": "inclusion",
            "atomicText": "Participation in another interventional study",
            "normalizedText": "Participation in another interventional study",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_3_1a",
              "groupLogic": "NOT",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 3
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "at the time of signing the informed consent.\n3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "Participation in other clinical trials is typically ascertained through patient interview at screening and documented in clinical notes, as it is not a standard structured data field. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0003",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Participation in other clinical trials is typically ascertained through patient interview at screening and documented in clinical notes, as it is not a standard structured data field."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Participation in another interventional study",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0004",
            "originalCriterionId": "INC_4",
            "criterionType": "inclusion",
            "atomicText": "Positive serum pregnancy test",
            "normalizedText": "Positive serum pregnancy test",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                42528957
              ],
              "conceptNames": [
                "Pregnancy status"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "82810-3"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "82810-3",
                  "display": "Pregnancy status"
                },
                {
                  "system": "http://snomed.info/sct",
                  "code": "77386006",
                  "display": "Pregnancy"
                }
              ],
              "searchParams": "code=http://loinc.org|82810-3,77386006",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_4_1a1",
              "groupLogic": "NOT",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 4
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "pregnancy_status",
            "expressionNodeId": "1a1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.98,
              "reasoning": "A serum pregnancy test is required at screening to determine current status, which falls under the definition of a new assessment at enrollment. The result is then recorded as a structured lab value. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0004",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [],
                "confidence": 0.98,
                "reasoning": "A serum pregnancy test is required at screening to determine current status, which falls under the definition of a new assessment at enrollment. The result is then recorded as a structured lab value."
              }
            }
          },
          {
            "atomicId": "A0005",
            "originalCriterionId": "INC_4",
            "criterionType": "inclusion",
            "atomicText": "Positive serum pregnancy test",
            "normalizedText": "Positive serum pregnancy test",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                42528957
              ],
              "conceptNames": [
                "Pregnancy status"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "82810-3"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "82810-3",
                  "display": "Pregnancy status"
                },
                {
                  "system": "http://snomed.info/sct",
                  "code": "77386006",
                  "display": "Pregnancy"
                }
              ],
              "searchParams": "code=http://loinc.org|82810-3,77386006",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_4_1b1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 5
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "pregnancy_status",
            "expressionNodeId": "1b1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.98,
              "reasoning": "A serum pregnancy test is required at screening to determine current status, which falls under the definition of a new assessment at enrollment. The result is then recorded as a structured lab value. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0005",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [],
                "confidence": 0.98,
                "reasoning": "A serum pregnancy test is required at screening to determine current status, which falls under the definition of a new assessment at enrollment. The result is then recorded as a structured lab value."
              }
            }
          },
          {
            "atomicId": "A0006",
            "originalCriterionId": "INC_4",
            "criterionType": "inclusion",
            "atomicText": "Demonstrated non-pregnant status through additional testing",
            "normalizedText": "Demonstrated non-pregnant status through additional testing",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                42528957
              ],
              "conceptNames": [
                "Pregnancy status"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "82810-3"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "82810-3",
                  "display": "Pregnancy status"
                },
                {
                  "system": "http://snomed.info/sct",
                  "code": "77386006",
                  "display": "Pregnancy"
                }
              ],
              "searchParams": "code=http://loinc.org|82810-3,77386006",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_4_1b2",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 6
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "pregnancy_status",
            "expressionNodeId": "1b2",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.98,
              "reasoning": "This requires performing new laboratory tests at screening to confirm pregnancy status, which is a real-time assessment. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0006",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [],
                "confidence": 0.98,
                "reasoning": "This requires performing new laboratory tests at screening to confirm pregnancy status, which is a real-time assessment."
              }
            }
          },
          {
            "atomicId": "A0007",
            "originalCriterionId": "INC_4",
            "criterionType": "inclusion",
            "atomicText": "At least one of the other specified conditions applies",
            "normalizedText": "At least one of the other specified conditions applies",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_4_2",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 7
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.9,
              "reasoning": "This criterion is a logical condition that requires an investigator to review and synthesize information from other criteria to make a final determination, which is a form of clinical judgment. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0007",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "This criterion is a logical condition that requires an investigator to review and synthesize information from other criteria to make a final determination, which is a form of clinical judgment."
              }
            }
          },
          {
            "atomicId": "A0008",
            "originalCriterionId": "INC_5",
            "criterionType": "inclusion",
            "atomicText": "Female",
            "normalizedText": "Female",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "person",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_5_1",
              "groupLogic": "IMPLICATION_CONDITION",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 8
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "the final administration of oxaliplatin and 6 months after the final administration of all \nother study drugs.\n5. Female subject must agree not to breastfeed starting at Screening and throughout the study \nperiod, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other stu...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Sex is a standard demographic field found in structured EHR data. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0008",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Sex is a standard demographic field found in structured EHR data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Female",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0009",
            "originalCriterionId": "INC_5",
            "criterionType": "inclusion",
            "atomicText": "Agrees not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration",
            "normalizedText": "Agrees not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_5_2",
              "groupLogic": "IMPLICATION_REQUIREMENT",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 9
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "the final administration of oxaliplatin and 6 months after the final administration of all \nother study drugs.\n5. Female subject must agree not to breastfeed starting at Screening and throughout the study \nperiod, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other stu...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 1.0,
              "reasoning": "The criterion is based on the patient's agreement ('Agrees not to') to a specific behavior, which is a patient decision documented during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0009",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The criterion is based on the patient's agreement ('Agrees not to') to a specific behavior, which is a patient decision documented during the consent process."
              }
            }
          },
          {
            "atomicId": "A0010",
            "originalCriterionId": "INC_6",
            "criterionType": "inclusion",
            "atomicText": "Female subject",
            "normalizedText": "Female subject",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "person",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female subject\n-- Requires manual SQL generation",
              "sqlExecutable": false,
              "valueConstraint": "gender_concept_id = 8532"
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_6_1",
              "groupLogic": "IMPLICATION_CONDITION",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 10
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Sex is a standard demographic field found in structured EHR data. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0010",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Sex is a standard demographic field found in structured EHR data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Female subject",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0011",
            "originalCriterionId": "INC_6",
            "criterionType": "inclusion",
            "atomicText": "Donate ova",
            "normalizedText": "Donate ova",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_6_2a1a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 11
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "ova_donation",
            "expressionNodeId": "2a1a",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 0.9,
              "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate ova, which is a patient decision made during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0011",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate ova, which is a patient decision made during the consent process."
              }
            }
          },
          {
            "atomicId": "A0012",
            "originalCriterionId": "INC_6",
            "criterionType": "inclusion",
            "atomicText": "Donate ova",
            "normalizedText": "Donate ova",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_6_2a2a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 12
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "ova_donation",
            "expressionNodeId": "2a2a",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 0.9,
              "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate ova, which is a patient decision made during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0012",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate ova, which is a patient decision made during the consent process."
              }
            }
          },
          {
            "atomicId": "A0013",
            "originalCriterionId": "INC_6",
            "criterionType": "inclusion",
            "atomicText": "Donate ova",
            "normalizedText": "Donate ova",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 51.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_6_2a3a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 13
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "ova_donation",
            "expressionNodeId": "2a3a",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 0.9,
              "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate ova, which is a patient decision made during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0013",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate ova, which is a patient decision made during the consent process."
              }
            }
          },
          {
            "atomicId": "A0014",
            "originalCriterionId": "INC_7",
            "criterionType": "inclusion",
            "atomicText": "Male subject",
            "normalizedText": "Male subject",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "person",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Male subject\n-- Requires manual SQL generation",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_7_1a",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 14
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Sex is a standard demographic field found in structured EHR data. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0014",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Sex is a standard demographic field found in structured EHR data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Male subject",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0015",
            "originalCriterionId": "INC_7",
            "criterionType": "inclusion",
            "atomicText": "Sexually active",
            "normalizedText": "Sexually active",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_7_1b",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 15
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "Sexual activity status is self-reported by the patient during an interview and documented in the social history section of clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0015",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Sexual activity status is self-reported by the patient during an interview and documented in the social history section of clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Sexually active",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0016",
            "originalCriterionId": "INC_7",
            "criterionType": "inclusion",
            "atomicText": "Has female partner(s) of childbearing potential",
            "normalizedText": "Has female partner(s) of childbearing potential",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                42528957
              ],
              "conceptNames": [
                "Pregnancy status"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "82810-3"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "82810-3",
                  "display": "Pregnancy status"
                },
                {
                  "system": "http://snomed.info/sct",
                  "code": "77386006",
                  "display": "Pregnancy"
                }
              ],
              "searchParams": "code=http://loinc.org|82810-3,77386006",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_7_1c",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 16
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1c",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "Information about a patient's partner(s) is obtained through patient interview and recorded in clinical or screening notes. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0016",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Information about a patient's partner(s) is obtained through patient interview and recorded in clinical or screening notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Has female partner(s) of childbearing potential",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0017",
            "originalCriterionId": "INC_7",
            "criterionType": "inclusion",
            "atomicText": "Agrees to use a condom during the treatment period and for at least 6 months after the final study drug administration",
            "normalizedText": "Agrees to use a condom during the treatment period and for at least 6 months after the final study drug administration",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                600058216
              ],
              "conceptNames": [
                "Other Investigational Agent"
              ],
              "vocabularyIds": [
                "NCIt_Full"
              ],
              "conceptCodes": [
                "C156875"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "MedicationStatement",
              "codes": [
                {
                  "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "code": "C156875",
                  "display": "Other Investigational Agent"
                }
              ],
              "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_7_2",
              "groupLogic": "IMPLICATION_REQUIREMENT",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 17
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "screening_only",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 1.0,
              "reasoning": "The criterion is based on the patient's agreement ('Agrees to use') to use contraception, which is a patient decision documented during the consent process. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0017",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The criterion is based on the patient's agreement ('Agrees to use') to use contraception, which is a patient decision documented during the consent process."
              }
            }
          },
          {
            "atomicId": "A0018",
            "originalCriterionId": "INC_8",
            "criterionType": "inclusion",
            "atomicText": "Sex is Male",
            "normalizedText": "Sex is Male",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "person",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Sex is Male\n-- Requires manual SQL generation",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_8_1",
              "groupLogic": "IMPLICATION_CONDITION",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 18
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study period and \nfor 6 months after the final study drug administration.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Sex is a standard demographic field found in structured EHR data. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0018",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Sex is a standard demographic field found in structured EHR data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Sex is Male",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0019",
            "originalCriterionId": "INC_8",
            "criterionType": "inclusion",
            "atomicText": "Sperm donation",
            "normalizedText": "Sperm donation",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_8_2a1",
              "groupLogic": "NOT",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 19
            },
            "provenance": {
              "pageNumber": 24,
              "textSnippet": "agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study period and \nfor 6 months after the final study drug administration.",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2a1",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 0.9,
              "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate sperm, which is a patient decision made during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0019",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "In the context of eligibility criteria, this typically refers to the patient agreeing not to donate sperm, which is a patient decision made during the consent process."
              }
            }
          },
          {
            "atomicId": "A0020",
            "originalCriterionId": "INC_9",
            "criterionType": "inclusion",
            "atomicText": "Subject is male",
            "normalizedText": "Subject is male",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "person",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Subject is male\n-- Requires manual SQL generation",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_9_1a",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 20
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Sex is a standard demographic field found in structured EHR data. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0020",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Sex is a standard demographic field found in structured EHR data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Subject is male",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0021",
            "originalCriterionId": "INC_9",
            "criterionType": "inclusion",
            "atomicText": "Partner is pregnant",
            "normalizedText": "Partner is pregnant",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                42528957
              ],
              "conceptNames": [
                "Pregnancy status"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "82810-3"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "82810-3",
                  "display": "Pregnancy status"
                },
                {
                  "system": "http://snomed.info/sct",
                  "code": "77386006",
                  "display": "Pregnancy"
                }
              ],
              "searchParams": "code=http://loinc.org|82810-3,77386006",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_9_1b1",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 21
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "partner_status",
            "expressionNodeId": "1b1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "The pregnancy status of a patient's partner is self-reported information documented in clinical or screening notes. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0021",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "The pregnancy status of a patient's partner is self-reported information documented in clinical or screening notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Partner is pregnant",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0022",
            "originalCriterionId": "INC_9",
            "criterionType": "inclusion",
            "atomicText": "Partner is breastfeeding",
            "normalizedText": "Partner is breastfeeding",
            "category": "demographics",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                42528957
              ],
              "conceptNames": [
                "Pregnancy status"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "82810-3"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "82810-3",
                  "display": "Pregnancy status"
                },
                {
                  "system": "http://snomed.info/sct",
                  "code": "77386006",
                  "display": "Pregnancy"
                }
              ],
              "searchParams": "code=http://loinc.org|82810-3,77386006",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_9_1b2",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 22
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "demographics",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "partner_status",
            "expressionNodeId": "1b2",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "The breastfeeding status of a patient's partner is self-reported information documented in clinical or screening notes. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0022",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "The breastfeeding status of a patient's partner is self-reported information documented in clinical or screening notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Partner is breastfeeding",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0023",
            "originalCriterionId": "INC_9",
            "criterionType": "inclusion",
            "atomicText": "Agrees to remain abstinent for the required duration",
            "normalizedText": "Agrees to remain abstinent for the required duration",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_9_2a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 23
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "screening_only",
            "clinicalConceptGroup": "contraception_agreement",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 1.0,
              "reasoning": "The criterion is based on the patient's agreement ('Agrees to remain abstinent') to a specific behavior, which is a patient decision documented during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0023",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The criterion is based on the patient's agreement ('Agrees to remain abstinent') to a specific behavior, which is a patient decision documented during the consent process."
              }
            }
          },
          {
            "atomicId": "A0024",
            "originalCriterionId": "INC_9",
            "criterionType": "inclusion",
            "atomicText": "Agrees to use a condom for the required duration",
            "normalizedText": "Agrees to use a condom for the required duration",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_9_2b",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 24
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
              "confidence": 1.0
            },
            "queryableStatus": "not_applicable",
            "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "screening_only",
            "clinicalConceptGroup": "contraception_agreement",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "NOT_APPLICABLE",
              "queryableStatus": "not_applicable",
              "confidence": 1.0,
              "reasoning": "The criterion is based on the patient's agreement ('Agrees to use a condom'), which is a patient decision documented during the consent process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0024",
                "primaryDataSource": "patient_decision",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The criterion is based on the patient's agreement ('Agrees to use a condom'), which is a patient decision documented during the consent process."
              }
            }
          },
          {
            "atomicId": "A0025",
            "originalCriterionId": "INC_10",
            "criterionType": "inclusion",
            "atomicText": "Histologically confirmed diagnosis",
            "normalizedText": "Histologically confirmed diagnosis",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_10_1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 25
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Histological confirmation is the primary finding of a pathology report, which serves as the source of truth for the diagnosis. No OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0025",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 1.0,
                "reasoning": "Histological confirmation is the primary finding of a pathology report, which serves as the source of truth for the diagnosis."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Histologically confirmed diagnosis",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0026",
            "originalCriterionId": "INC_10",
            "criterionType": "inclusion",
            "atomicText": "Gastric adenocarcinoma",
            "normalizedText": "Gastric adenocarcinoma",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                196044
              ],
              "conceptNames": [
                "Primary malignant neoplasm of stomach"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "372014001"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "372014001",
                  "display": "Primary malignant neoplasm of stomach"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "C16.9",
                  "display": "Malignant neoplasm of stomach, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|372014001,C16.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_10_2a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 26
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_or_gej_adenocarcinoma",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 1.0,
              "reasoning": "The specific histology (adenocarcinoma) and location (gastric) are definitively determined and documented in the pathology report. This may also be recorded as an ICD code. Has OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0026",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 1.0,
                "reasoning": "The specific histology (adenocarcinoma) and location (gastric) are definitively determined and documented in the pathology report. This may also be recorded as an ICD code."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Gastric adenocarcinoma",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0027",
            "originalCriterionId": "INC_10",
            "criterionType": "inclusion",
            "atomicText": "Gastroesophageal junction (GEJ) adenocarcinoma",
            "normalizedText": "Gastroesophageal junction (GEJ) adenocarcinoma",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_10_2b",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 27
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_or_gej_adenocarcinoma",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "The specific histology (adenocarcinoma) and location (GEJ) are definitively determined and documented in the pathology report. This may also be recorded as an ICD code. No OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0027",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 1.0,
                "reasoning": "The specific histology (adenocarcinoma) and location (GEJ) are definitively determined and documented in the pathology report. This may also be recorded as an ICD code."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Gastroesophageal junction (GEJ) adenocarcinoma",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0028",
            "originalCriterionId": "INC_11",
            "criterionType": "inclusion",
            "atomicText": "Disease is radiologically confirmed",
            "normalizedText": "Disease is radiologically confirmed",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND o.observation_date >= @reference_date - INTERVAL '28 days'",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_11_1a1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 28
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1a1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "The term 'radiologically confirmed' directly points to an imaging study, with the findings documented in a radiology report (e.g., CT, MRI, PET scan). No OMOP mapping. Data in: Radiology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0028",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Radiology"
                ],
                "confidence": 1.0,
                "reasoning": "The term 'radiologically confirmed' directly points to an imaging study, with the findings documented in a radiology report (e.g., CT, MRI, PET scan)."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology"
                ],
                "extractionPrompt": "Extract: Disease is radiologically confirmed",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0029",
            "originalCriterionId": "INC_11",
            "criterionType": "inclusion",
            "atomicText": "Locally advanced unresectable disease",
            "normalizedText": "Locally advanced unresectable disease",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                37165616
              ],
              "conceptNames": [
                "Locally advanced malignant neoplasm"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "1255249000"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "1255249000",
                  "display": "Locally advanced malignant neoplasm"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|1255249000",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_11_1a2a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 29
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "advanced_unresectable_or_metastatic_disease",
            "expressionNodeId": "1a2a",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "The extent of disease ('locally advanced') is determined by imaging and found in radiology reports. The 'unresectable' status is a clinical conclusion, often documented in progress or surgical consult notes, based on those imaging findings. Has OMOP mapping. Data in: Radiology, Progress Note, Consult Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0029",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Radiology",
                  "Progress Note",
                  "Consult Note"
                ],
                "confidence": 0.95,
                "reasoning": "The extent of disease ('locally advanced') is determined by imaging and found in radiology reports. The 'unresectable' status is a clinical conclusion, often documented in progress or surgical consult notes, based on those imaging findings."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology",
                  "Progress Note",
                  "Consult Note"
                ],
                "extractionPrompt": "Extract: Locally advanced unresectable disease",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0030",
            "originalCriterionId": "INC_11",
            "criterionType": "inclusion",
            "atomicText": "Metastatic disease",
            "normalizedText": "Metastatic disease",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                432851
              ],
              "conceptNames": [
                "Metastatic malignant neoplasm"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "128462008"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (432851)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "128462008",
                  "display": "Metastatic malignant neoplasm"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|128462008",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_11_1a2b",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 30
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "advanced_unresectable_or_metastatic_disease",
            "expressionNodeId": "1a2b",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 1.0,
              "reasoning": "The presence of metastatic disease is identified and documented in radiology reports from staging scans (e.g., CT, PET). It is often coded as a secondary diagnosis as well. Has OMOP mapping. Data in: Radiology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0030",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Radiology"
                ],
                "confidence": 1.0,
                "reasoning": "The presence of metastatic disease is identified and documented in radiology reports from staging scans (e.g., CT, PET). It is often coded as a secondary diagnosis as well."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology"
                ],
                "extractionPrompt": "Extract: Metastatic disease",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0031",
            "originalCriterionId": "INC_12",
            "criterionType": "inclusion",
            "atomicText": "Radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment",
            "normalizedText": "Radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 10.0,
              "impactScore": 0.1,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_12_1a",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 31
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.95,
              "reasoning": "This criterion requires a new imaging assessment at baseline to confirm the presence of evaluable disease according to RECIST 1.1 standards for the trial. The result is documented in a radiology report. No OMOP mapping. Data in: Radiology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0031",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": "radiology_report",
                "noteTypes": [
                  "Radiology"
                ],
                "confidence": 0.95,
                "reasoning": "This criterion requires a new imaging assessment at baseline to confirm the presence of evaluable disease according to RECIST 1.1 standards for the trial. The result is documented in a radiology report."
              }
            }
          },
          {
            "atomicId": "A0032",
            "originalCriterionId": "INC_12",
            "criterionType": "inclusion",
            "atomicText": "Subject has only 1 evaluable lesion",
            "normalizedText": "Subject has only 1 evaluable lesion",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 10.0,
              "impactScore": 0.1,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_12_2a",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 32
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "The number of evaluable lesions is a specific finding documented in the radiology report from the baseline imaging assessment required for the trial. No OMOP mapping. Data in: Radiology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0032",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "real_time_assessment",
                "noteTypes": [
                  "Radiology"
                ],
                "confidence": 0.9,
                "reasoning": "The number of evaluable lesions is a specific finding documented in the radiology report from the baseline imaging assessment required for the trial."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology"
                ],
                "extractionPrompt": "Extract: Subject has only 1 evaluable lesion",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0033",
            "originalCriterionId": "INC_12",
            "criterionType": "inclusion",
            "atomicText": "History of radiotherapy",
            "normalizedText": "History of radiotherapy",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 10.0,
              "impactScore": 0.1,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND po.procedure_date >= @reference_date - INTERVAL '3 months'",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_12_2b1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 33
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "2b1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "A patient's history of prior treatments, such as radiotherapy, is most reliably and comprehensively documented in narrative clinical notes and treatment summaries. No OMOP mapping. Data in: Progress Note, Radiation Oncology Note, H&P, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0033",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "Radiation Oncology Note",
                  "H&P",
                  "Discharge Summary"
                ],
                "confidence": 0.95,
                "reasoning": "A patient's history of prior treatments, such as radiotherapy, is most reliably and comprehensively documented in narrative clinical notes and treatment summaries."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Radiation Oncology Note",
                  "H&P",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: History of radiotherapy",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0034",
            "originalCriterionId": "INC_12",
            "criterionType": "inclusion",
            "atomicText": "The evaluable lesion is outside the field of prior radiotherapy",
            "normalizedText": "The evaluable lesion is outside the field of prior radiotherapy",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 10.0,
              "impactScore": 0.1,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [
                600054592
              ],
              "conceptNames": [
                "Radiation Therapy"
              ],
              "vocabularyIds": [
                "NCIt_Full"
              ],
              "conceptCodes": [
                "C15313"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Procedure",
              "codes": [
                {
                  "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "code": "C15313",
                  "display": "Radiation Therapy"
                }
              ],
              "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_12_2c",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 34
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2c",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "This requires comparing the location of the current evaluable lesion (from a new radiology report) with the historical radiation field (from clinical/radiation oncology notes). The primary source for the lesion's location is the radiology report. Has OMOP mapping. Data in: Radiology, Radiation Oncology Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0034",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Radiology",
                  "Radiation Oncology Note"
                ],
                "confidence": 0.9,
                "reasoning": "This requires comparing the location of the current evaluable lesion (from a new radiology report) with the historical radiation field (from clinical/radiation oncology notes). The primary source for the lesion's location is the radiology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology",
                  "Radiation Oncology Note"
                ],
                "extractionPrompt": "Extract: The evaluable lesion is outside the field of prior radiotherapy",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0035",
            "originalCriterionId": "INC_12",
            "criterionType": "inclusion",
            "atomicText": "The evaluable lesion has documented progression following radiation therapy",
            "normalizedText": "The evaluable lesion has documented progression following radiation therapy",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 10.0,
              "impactScore": 0.1,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [
                600054592
              ],
              "conceptNames": [
                "Radiation Therapy"
              ],
              "vocabularyIds": [
                "NCIt_Full"
              ],
              "conceptCodes": [
                "C15313"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Procedure",
              "codes": [
                {
                  "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "code": "C15313",
                  "display": "Radiation Therapy"
                }
              ],
              "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_12_2d",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 35
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2d",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "Documented progression of a lesion is an assessment made by a radiologist comparing scans over time, with the conclusion stated in a radiology report. Has OMOP mapping. Data in: Radiology, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0035",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Radiology",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Documented progression of a lesion is an assessment made by a radiologist comparing scans over time, with the conclusion stated in a radiology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: The evaluable lesion has documented progression following radiation therapy",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0036",
            "originalCriterionId": "INC_13",
            "criterionType": "inclusion",
            "atomicText": "Tumor expresses CLDN18.2",
            "normalizedText": "Tumor expresses CLDN18.2",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false,
              "valueConstraint": "Positive"
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_13_1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 36
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "biomarker",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "cldn18_2_status",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "CLDN18.2 is a protein biomarker. Its expression is determined by lab analysis (e.g., IHC) of a tumor specimen, with results documented in a pathology report. No OMOP mapping. Data in: Pathology, Molecular Diagnostics",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0036",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "confidence": 1.0,
                "reasoning": "CLDN18.2 is a protein biomarker. Its expression is determined by lab analysis (e.g., IHC) of a tumor specimen, with results documented in a pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "extractionPrompt": "Extract: Tumor expresses CLDN18.2",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0037",
            "originalCriterionId": "INC_13",
            "criterionType": "inclusion",
            "atomicText": "CLDN18.2 expression in >= 75% of tumor cells",
            "normalizedText": "CLDN18.2 expression in >= 75% of tumor cells",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND m.value_as_number >= 75",
              "sqlExecutable": false,
              "valueConstraint": "value_as_number >= 75"
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_13_2",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 37
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "biomarker",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "cldn18_2_status",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "The specific percentage of tumor cells expressing a biomarker is a quantitative finding detailed exclusively in the pathology report. No OMOP mapping. Data in: Pathology, Molecular Diagnostics",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0037",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "confidence": 1.0,
                "reasoning": "The specific percentage of tumor cells expressing a biomarker is a quantitative finding detailed exclusively in the pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "extractionPrompt": "Extract: CLDN18.2 expression in >= 75% of tumor cells",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0038",
            "originalCriterionId": "INC_13",
            "criterionType": "inclusion",
            "atomicText": "CLDN18.2 demonstrates moderate to strong membranous staining",
            "normalizedText": "CLDN18.2 demonstrates moderate to strong membranous staining",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false,
              "valueConstraint": "staining intensity in ['moderate', 'strong'] and location is 'membranous'"
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_13_3",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 38
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "biomarker",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "cldn18_2_status",
            "expressionNodeId": "3",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 1.0,
              "reasoning": "Staining intensity and pattern (e.g., 'moderate to strong membranous') are qualitative assessments made by a pathologist and documented in the pathology report. No OMOP mapping. Data in: Pathology, Molecular Diagnostics",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0038",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "confidence": 1.0,
                "reasoning": "Staining intensity and pattern (e.g., 'moderate to strong membranous') are qualitative assessments made by a pathologist and documented in the pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "extractionPrompt": "Extract: CLDN18.2 demonstrates moderate to strong membranous staining",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0039",
            "originalCriterionId": "INC_13",
            "criterionType": "inclusion",
            "atomicText": "CLDN18.2 status determined by central IHC testing",
            "normalizedText": "CLDN18.2 status determined by central IHC testing",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_13_4",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 39
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "cldn18_2_status",
            "expressionNodeId": "4",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "Confirmation that testing was performed by a specific type of lab (central) would be documented on the official pathology report from that laboratory. No OMOP mapping. Data in: Pathology, Molecular Diagnostics",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0039",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "confidence": 0.98,
                "reasoning": "Confirmation that testing was performed by a specific type of lab (central) would be documented on the official pathology report from that laboratory."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "extractionPrompt": "Extract: CLDN18.2 status determined by central IHC testing",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0040",
            "originalCriterionId": "INC_14",
            "criterionType": "inclusion",
            "atomicText": "HER2-negative tumor status",
            "normalizedText": "HER2-negative tumor status",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 20.0,
              "impactScore": 0.2,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [
                3019066
              ],
              "conceptNames": [
                "HER2 Ag [Presence] in Tissue by Immune stain"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "18474-7"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3019066) AND Result is 'Negative' or equivalent concept for HER2 test",
              "sqlExecutable": true,
              "valueConstraint": "Result is 'Negative' or equivalent concept for HER2 test"
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "62862-8",
                  "display": "ERBB2 gene amplification analysis"
                }
              ],
              "searchParams": "code=http://loinc.org|62862-8",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_14_1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 40
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "biomarker",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "her2_status",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 1.0,
              "reasoning": "HER2 status is a standard biomarker determined from a tumor specimen via IHC/FISH, and the definitive result is found in the pathology report. Has OMOP mapping. Data in: Pathology, Molecular Diagnostics",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0040",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "confidence": 1.0,
                "reasoning": "HER2 status is a standard biomarker determined from a tumor specimen via IHC/FISH, and the definitive result is found in the pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "extractionPrompt": "Extract: HER2-negative tumor status",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0041",
            "originalCriterionId": "INC_14",
            "criterionType": "inclusion",
            "atomicText": "Gastric tumor",
            "normalizedText": "Gastric tumor",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_14_2a",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 41
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "primary_tumor_location",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "The definitive diagnosis of a tumor's primary site (gastric) and histology is established by a pathologist's review of a tissue sample, documented in a pathology report. No OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0041",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 0.98,
                "reasoning": "The definitive diagnosis of a tumor's primary site (gastric) and histology is established by a pathologist's review of a tissue sample, documented in a pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Gastric tumor",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0042",
            "originalCriterionId": "INC_14",
            "criterionType": "inclusion",
            "atomicText": "Gastroesophageal junction (GEJ) tumor",
            "normalizedText": "Gastroesophageal junction (GEJ) tumor",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_14_2b",
              "groupLogic": "OR",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 42
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "primary_tumor_location",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "The definitive diagnosis of a tumor's primary site (GEJ) and histology is established by a pathologist's review of a tissue sample, documented in a pathology report. No OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0042",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 0.98,
                "reasoning": "The definitive diagnosis of a tumor's primary site (GEJ) and histology is established by a pathologist's review of a tissue sample, documented in a pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Gastroesophageal junction (GEJ) tumor",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0043",
            "originalCriterionId": "INC_14",
            "criterionType": "inclusion",
            "atomicText": "HER2 status determined on a tumor specimen by local or central testing",
            "normalizedText": "HER2 status determined on a tumor specimen by local or central testing",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 20.0,
              "impactScore": 0.2,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [
                3019066
              ],
              "conceptNames": [
                "HER2 Ag [Presence] in Tissue by Immune stain"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "18474-7"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3019066)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "62862-8",
                  "display": "ERBB2 gene amplification analysis"
                }
              ],
              "searchParams": "code=http://loinc.org|62862-8",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_14_3",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 43
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "3",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.98,
              "reasoning": "The pathology report for the HER2 test will contain the necessary details about the specimen and the testing laboratory (local or central). Has OMOP mapping. Data in: Pathology, Molecular Diagnostics",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0043",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "confidence": 0.98,
                "reasoning": "The pathology report for the HER2 test will contain the necessary details about the specimen and the testing laboratory (local or central)."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology",
                  "Molecular Diagnostics"
                ],
                "extractionPrompt": "Extract: HER2 status determined on a tumor specimen by local or central testing",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0044",
            "originalCriterionId": "INC_15",
            "criterionType": "inclusion",
            "atomicText": "ECOG performance status 0-1",
            "normalizedText": "ECOG performance status 0-1",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 25.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [
                36305384
              ],
              "conceptNames": [
                "ECOG Performance Status score"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "89247-1"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND value_as_number >= 0 AND value_as_number <= 1",
              "sqlExecutable": true,
              "valueConstraint": "value_as_number >= 0 AND value_as_number <= 1"
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "89247-1",
                  "display": "ECOG Performance Status score"
                }
              ],
              "searchParams": "code=http://loinc.org|89247-1",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_15_1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 44
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "tumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibil...",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "performance_status",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "ECOG performance status is a scale assessed by a clinician during a physical examination at the time of screening or baseline for the trial. Has OMOP mapping. Data in: Progress Note, H&P",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0044",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Progress Note",
                  "H&P"
                ],
                "confidence": 1.0,
                "reasoning": "ECOG performance status is a scale assessed by a clinician during a physical examination at the time of screening or baseline for the trial."
              }
            }
          },
          {
            "atomicId": "A0045",
            "originalCriterionId": "INC_16",
            "criterionType": "inclusion",
            "atomicText": "Predicted life expectancy \u2265 12 weeks in the opinion of the investigator",
            "normalizedText": "Predicted life expectancy \u2265 12 weeks in the opinion of the investigator",
            "category": "performance_status",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                3050013
              ],
              "conceptNames": [
                "Life expectancy [OASIS]"
              ],
              "vocabularyIds": [
                "LOINC"
              ],
              "conceptCodes": [
                "46525-2"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (3050013) AND value_as_number >= 12",
              "sqlExecutable": true,
              "valueConstraint": "value_as_number >= 12"
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://loinc.org",
                  "code": "46525-2",
                  "display": "Life expectancy [OASIS]"
                }
              ],
              "searchParams": "code=http://loinc.org|46525-2",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_INC_16_1",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 45
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "Physical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibility. \na....",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "performance_status",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "The phrase 'in the opinion of the investigator' explicitly indicates that this is a subjective assessment requiring clinical judgment. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0045",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The phrase 'in the opinion of the investigator' explicitly indicates that this is a subjective assessment requiring clinical judgment."
              }
            }
          },
          {
            "atomicId": "A0046",
            "originalCriterionId": "INC_17",
            "criterionType": "inclusion",
            "atomicText": "Required laboratory tests for eligibility assessment collected",
            "normalizedText": "Required laboratory tests for eligibility assessment collected",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 25.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "measurement",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_INC_17_root_a",
              "groupLogic": "AND",
              "combineWithPrevious": "AND",
              "isExclusion": false,
              "sequenceHint": 46
            },
            "provenance": {
              "pageNumber": 25,
              "textSnippet": "16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibility. \na. Hemoglobin (Hgb) \u2265 9 g/dL. Subjects requiring transfusions are eligible if they...",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "diagnostic_confirmation",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "root_a",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.9,
              "reasoning": "This is a procedural check to confirm that all necessary actions (sample collection for lab tests) have been completed as part of the screening process. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0046",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "This is a procedural check to confirm that all necessary actions (sample collection for lab tests) have been completed as part of the screening process."
              }
            }
          },
          {
            "atomicId": "A0047",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma",
            "normalizedText": "Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                37165616
              ],
              "conceptNames": [
                "Locally advanced malignant neoplasm"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "1255249000"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "1255249000",
                  "display": "Locally advanced malignant neoplasm"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|1255249000",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_1_1",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 47
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "Detailed prior treatment history, including the specific indication (locally advanced unresectable or metastatic) and disease type, is most reliably found in narrative clinical notes. Has OMOP mapping. Data in: Progress Note, Oncology Note, Treatment Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0047",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "confidence": 0.95,
                "reasoning": "Detailed prior treatment history, including the specific indication (locally advanced unresectable or metastatic) and disease type, is most reliably found in narrative clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "extractionPrompt": "Extract: Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0048",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Received neo-adjuvant or adjuvant chemotherapy",
            "normalizedText": "Received neo-adjuvant or adjuvant chemotherapy",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "drug_exposure",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_1_2a1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 48
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "prior_systemic_therapy",
            "expressionNodeId": "2a1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "The specific context of chemotherapy (neo-adjuvant or adjuvant) is crucial information documented in narrative clinical notes, not typically available in structured medication data. No OMOP mapping. Data in: Progress Note, Oncology Note, Treatment Summary, Surgical Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0048",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary",
                  "Surgical Note"
                ],
                "confidence": 0.95,
                "reasoning": "The specific context of chemotherapy (neo-adjuvant or adjuvant) is crucial information documented in narrative clinical notes, not typically available in structured medication data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary",
                  "Surgical Note"
                ],
                "extractionPrompt": "Extract: Received neo-adjuvant or adjuvant chemotherapy",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0049",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Received immunotherapy",
            "normalizedText": "Received immunotherapy",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "drug_exposure",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_1_2a2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 49
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "prior_systemic_therapy",
            "expressionNodeId": "2a2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "History of prior immunotherapy, including specific agents and dates, is best captured from clinical notes and treatment summaries. No OMOP mapping. Data in: Progress Note, Oncology Note, Treatment Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0049",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "confidence": 0.95,
                "reasoning": "History of prior immunotherapy, including specific agents and dates, is best captured from clinical notes and treatment summaries."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "extractionPrompt": "Extract: Received immunotherapy",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0050",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Received other systemic anticancer therapies",
            "normalizedText": "Received other systemic anticancer therapies",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_1_2a3",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 50
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "prior_systemic_therapy",
            "expressionNodeId": "2a3",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "A comprehensive history of all prior systemic anticancer therapies is compiled from a review of narrative clinical notes and treatment summaries. Has OMOP mapping. Data in: Progress Note, Oncology Note, Treatment Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0050",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "confidence": 0.95,
                "reasoning": "A comprehensive history of all prior systemic anticancer therapies is compiled from a review of narrative clinical notes and treatment summaries."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "extractionPrompt": "Extract: Received other systemic anticancer therapies",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0051",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy",
            "normalizedText": "Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_1_2b1a",
              "groupLogic": "NOT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 51
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "2b1a",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "The completion date and status of prior therapies are details documented in narrative form within clinical notes or treatment summaries. Has OMOP mapping. Data in: Progress Note, Oncology Note, Treatment Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0051",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "confidence": 0.95,
                "reasoning": "The completion date and status of prior therapies are details documented in narrative form within clinical notes or treatment summaries."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Oncology Note",
                  "Treatment Summary"
                ],
                "extractionPrompt": "Extract: Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0052",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Received treatment with herbal medications that have known antitumor activity",
            "normalizedText": "Received treatment with herbal medications that have known antitumor activity",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "drug_exposure",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_1_3a",
              "groupLogic": "IMPLICATION_CONDITION",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 52
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "3a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "Use of non-prescribed treatments like herbal medications is not captured in structured pharmacy data and must be elicited from the patient and documented in clinical notes. No OMOP mapping. Data in: H&P, Progress Note, Medication Reconciliation Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0052",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Medication Reconciliation Note"
                ],
                "confidence": 0.98,
                "reasoning": "Use of non-prescribed treatments like herbal medications is not captured in structured pharmacy data and must be elicited from the patient and documented in clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Medication Reconciliation Note"
                ],
                "extractionPrompt": "Extract: Received treatment with herbal medications that have known antitumor activity",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0053",
            "originalCriterionId": "EXC_1",
            "criterionType": "exclusion",
            "atomicText": "Completion of treatment with herbal medications with known antitumor activity",
            "normalizedText": "Completion of treatment with herbal medications with known antitumor activity",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 40.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_1_3b1a",
              "groupLogic": "NOT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 53
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "3b1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "The timing and completion of non-prescribed treatments like herbal medications are based on patient reporting documented in clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0053",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.98,
                "reasoning": "The timing and completion of non-prescribed treatments like herbal medications are based on patient reporting documented in clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Completion of treatment with herbal medications with known antitumor activity",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0054",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "atomicText": "Received radiotherapy",
            "normalizedText": "Received radiotherapy",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 10.0,
              "impactScore": 0.1,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_2_1a",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 54
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "A patient's history of prior treatments, such as radiotherapy, is most reliably and comprehensively documented in narrative clinical notes and treatment summaries. No OMOP mapping. Data in: Progress Note, Radiation Oncology Note, H&P, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0054",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "Radiation Oncology Note",
                  "H&P",
                  "Discharge Summary"
                ],
                "confidence": 0.95,
                "reasoning": "A patient's history of prior treatments, such as radiotherapy, is most reliably and comprehensively documented in narrative clinical notes and treatment summaries."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Radiation Oncology Note",
                  "H&P",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: Received radiotherapy",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0055",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "atomicText": "Diagnosis of gastric adenocarcinoma",
            "normalizedText": "Diagnosis of gastric adenocarcinoma",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                196044
              ],
              "conceptNames": [
                "Primary malignant neoplasm of stomach"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "372014001"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "372014001",
                  "display": "Primary malignant neoplasm of stomach"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "C16.9",
                  "display": "Malignant neoplasm of stomach, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|372014001,C16.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_2_2a1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 55
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_gej_adenocarcinoma",
            "expressionNodeId": "2a1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.98,
              "reasoning": "The definitive diagnosis, including histology (adenocarcinoma) and primary site (gastric), is established in the pathology report. Has OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0055",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 0.98,
                "reasoning": "The definitive diagnosis, including histology (adenocarcinoma) and primary site (gastric), is established in the pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Diagnosis of gastric adenocarcinoma",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0056",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "atomicText": "Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma",
            "normalizedText": "Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_2_2a2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 56
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_gej_adenocarcinoma",
            "expressionNodeId": "2a2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "The definitive diagnosis, including histology (adenocarcinoma) and primary site (GEJ), is established in the pathology report. No OMOP mapping. Data in: Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0056",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Pathology"
                ],
                "confidence": 0.98,
                "reasoning": "The definitive diagnosis, including histology (adenocarcinoma) and primary site (GEJ), is established in the pathology report."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0057",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "atomicText": "Disease is locally advanced unresectable",
            "normalizedText": "Disease is locally advanced unresectable",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                37165616
              ],
              "conceptNames": [
                "Locally advanced malignant neoplasm"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "1255249000"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "1255249000",
                  "display": "Locally advanced malignant neoplasm"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|1255249000",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_2_2b1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 57
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "disease_stage_unresectable_metastatic",
            "expressionNodeId": "2b1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "The determination of 'locally advanced unresectable' disease is primarily based on findings from imaging reports, often synthesized with surgical opinions documented in clinical notes. Has OMOP mapping. Data in: Radiology, Progress Note, Surgical Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0057",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Radiology",
                  "Progress Note",
                  "Surgical Note"
                ],
                "confidence": 0.9,
                "reasoning": "The determination of 'locally advanced unresectable' disease is primarily based on findings from imaging reports, often synthesized with surgical opinions documented in clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology",
                  "Progress Note",
                  "Surgical Note"
                ],
                "extractionPrompt": "Extract: Disease is locally advanced unresectable",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0058",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "atomicText": "Disease is metastatic",
            "normalizedText": "Disease is metastatic",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 60.0,
              "impactScore": 0.8,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_2_2b2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 58
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "disease_stage_unresectable_metastatic",
            "expressionNodeId": "2b2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "The presence of metastatic disease is identified and documented in radiology reports from staging scans (e.g., CT, PET). A metastasis may also be confirmed by biopsy. No OMOP mapping. Data in: Radiology, Pathology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0058",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "pathology_report",
                "noteTypes": [
                  "Radiology",
                  "Pathology"
                ],
                "confidence": 0.98,
                "reasoning": "The presence of metastatic disease is identified and documented in radiology reports from staging scans (e.g., CT, PET). A metastasis may also be confirmed by biopsy."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology",
                  "Pathology"
                ],
                "extractionPrompt": "Extract: Disease is metastatic",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0059",
            "originalCriterionId": "EXC_2",
            "criterionType": "exclusion",
            "atomicText": "Recovered from radiotherapy-related toxicity",
            "normalizedText": "Recovered from radiotherapy-related toxicity",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_2_3a",
              "groupLogic": "NOT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 59
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "3a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Recovery from treatment-related toxicity is a clinical assessment documented by a provider in a progress note, which must be confirmed at the screening visit. No OMOP mapping. Data in: Progress Note, H&P",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0059",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "real_time_assessment",
                "noteTypes": [
                  "Progress Note",
                  "H&P"
                ],
                "confidence": 0.9,
                "reasoning": "Recovery from treatment-related toxicity is a clinical assessment documented by a provider in a progress note, which must be confirmed at the screening visit."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "H&P"
                ],
                "extractionPrompt": "Extract: Recovered from radiotherapy-related toxicity",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0060",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "atomicText": "Received systemic immunosuppressive therapy",
            "normalizedText": "Received systemic immunosuppressive therapy",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_3_1a1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 60
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "systemic_immunosuppression",
            "expressionNodeId": "1a1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "History of immunosuppressive therapy is best captured from clinical notes, which provide important context (e.g., indication, dates) that may be missing from structured medication data. Has OMOP mapping. Data in: Progress Note, H&P, Medication Reconciliation Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0060",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Progress Note",
                  "H&P",
                  "Medication Reconciliation Note"
                ],
                "confidence": 0.95,
                "reasoning": "History of immunosuppressive therapy is best captured from clinical notes, which provide important context (e.g., indication, dates) that may be missing from structured medication data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "H&P",
                  "Medication Reconciliation Note"
                ],
                "extractionPrompt": "Extract: Received systemic immunosuppressive therapy",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0061",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "atomicText": "Received systemic corticosteroids",
            "normalizedText": "Received systemic corticosteroids",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_3_1a2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 61
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "systemic_immunosuppression",
            "expressionNodeId": "1a2",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.9,
              "reasoning": "History of receiving systemic corticosteroids would be most reliably found in structured medication administration or prescription records (e.g., RxNorm, NDC codes). Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0061",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 0.9,
                "reasoning": "History of receiving systemic corticosteroids would be most reliably found in structured medication administration or prescription records (e.g., RxNorm, NDC codes)."
              }
            }
          },
          {
            "atomicId": "A0062",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "atomicText": "Received hydrocortisone at a physiologic replacement dose up to 30 mg/day",
            "normalizedText": "Received hydrocortisone at a physiologic replacement dose up to 30 mg/day",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [
                1243048
              ],
              "conceptNames": [
                "Systemic corticosteroid therapy"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "1290388005"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
              "sqlExecutable": true,
              "valueConstraint": "value_as_number <= 30"
            },
            "fhirQuery": {
              "resourceType": "MedicationStatement",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "1290388005",
                  "display": "Systemic corticosteroid therapy"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|1290388005",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_3_2a1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 62
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "physiologic_steroid_dose",
            "expressionNodeId": "2a1",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.95,
              "reasoning": "The specific medication (hydrocortisone) and dose are best captured in structured medication data (prescription or administration records). Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0062",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 0.95,
                "reasoning": "The specific medication (hydrocortisone) and dose are best captured in structured medication data (prescription or administration records)."
              }
            }
          },
          {
            "atomicId": "A0063",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "atomicText": "Received prednisone at a physiologic replacement dose up to 10 mg/day",
            "normalizedText": "Received prednisone at a physiologic replacement dose up to 10 mg/day",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [
                1243048
              ],
              "conceptNames": [
                "Systemic corticosteroid therapy"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "1290388005"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
              "sqlExecutable": true,
              "valueConstraint": "value_as_number <= 10"
            },
            "fhirQuery": {
              "resourceType": "MedicationStatement",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "1290388005",
                  "display": "Systemic corticosteroid therapy"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|1290388005",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_3_2a2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 63
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "physiologic_steroid_dose",
            "expressionNodeId": "2a2",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.95,
              "reasoning": "The specific medication (prednisone) and dose are best captured in structured medication data (prescription or administration records). Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0063",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 0.95,
                "reasoning": "The specific medication (prednisone) and dose are best captured in structured medication data (prescription or administration records)."
              }
            }
          },
          {
            "atomicId": "A0064",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "atomicText": "Received a single dose of systemic corticosteroids",
            "normalizedText": "Received a single dose of systemic corticosteroids",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_3_2b",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 64
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.85,
              "reasoning": "While the medication administration would be in structured data, the context of it being a 'single dose' might be more clearly specified in clinical notes. Structured data is still the primary source for the medication itself. Has OMOP mapping. Data in: Progress Note, H&P",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0064",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Progress Note",
                  "H&P"
                ],
                "confidence": 0.85,
                "reasoning": "While the medication administration would be in structured data, the context of it being a 'single dose' might be more clearly specified in clinical notes. Structured data is still the primary source for the medication itself."
              }
            }
          },
          {
            "atomicId": "A0065",
            "originalCriterionId": "EXC_3",
            "criterionType": "exclusion",
            "atomicText": "Received systemic corticosteroids as premedication for radiologic imaging contrast use",
            "normalizedText": "Received systemic corticosteroids as premedication for radiologic imaging contrast use",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_3_2c",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 65
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2c",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "The reason for the corticosteroid administration (premedication for contrast) is clinical context that is almost exclusively found in narrative notes, such as radiology or progress notes. Has OMOP mapping. Data in: Radiology, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0065",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Radiology",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "The reason for the corticosteroid administration (premedication for contrast) is clinical context that is almost exclusively found in narrative notes, such as radiology or progress notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Received systemic corticosteroids as premedication for radiologic imaging contrast use",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0066",
            "originalCriterionId": "EXC_4",
            "criterionType": "exclusion",
            "atomicText": "Received other investigational agents",
            "normalizedText": "Received other investigational agents",
            "category": "prior_therapy",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                600058216
              ],
              "conceptNames": [
                "Other Investigational Agent"
              ],
              "vocabularyIds": [
                "NCIt_Full"
              ],
              "conceptCodes": [
                "C156875"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "MedicationStatement",
              "codes": [
                {
                  "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "code": "C156875",
                  "display": "Other Investigational Agent"
                }
              ],
              "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_4_1a1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 66
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.\n4. Subject has received other investigational agents or devices within 28 days prior to \nrandomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "investigational_product_exposure",
            "expressionNodeId": "1a1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.98,
              "reasoning": "Prior participation in clinical trials and receipt of investigational agents is documented in the patient's medical history narrative within clinical notes, as it is not typically captured in structured data fields. Has OMOP mapping. Data in: H&P, Progress Note, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0066",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Discharge Summary"
                ],
                "confidence": 0.98,
                "reasoning": "Prior participation in clinical trials and receipt of investigational agents is documented in the patient's medical history narrative within clinical notes, as it is not typically captured in structured data fields."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: Received other investigational agents",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0067",
            "originalCriterionId": "EXC_4",
            "criterionType": "exclusion",
            "atomicText": "Received other investigational devices",
            "normalizedText": "Received other investigational devices",
            "category": "prior_therapy",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "device_exposure",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM device_exposure de\nWHERE de.device_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_4_1a2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 67
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.\n4. Subject has received other investigational agents or devices within 28 days prior to \nrandomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "prior_therapy",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "investigational_product_exposure",
            "expressionNodeId": "1a2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "Prior use of investigational devices is documented in the patient's medical history narrative within clinical notes, as it is not typically captured in structured data fields. No OMOP mapping. Data in: H&P, Progress Note, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0067",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Discharge Summary"
                ],
                "confidence": 0.98,
                "reasoning": "Prior use of investigational devices is documented in the patient's medical history narrative within clinical notes, as it is not typically captured in structured data fields."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: Received other investigational devices",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0068",
            "originalCriterionId": "EXC_5",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab",
            "normalizedText": "Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_5_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 68
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "zolbetuximab_hypersensitivity",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "While an allergy may be listed in a structured allergy module, the details of a 'severe allergic reaction or intolerance' are best described in clinical notes, making them the more reliable source for this level of detail. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0068",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "While an allergy may be listed in a structured allergy module, the details of a 'severe allergic reaction or intolerance' are best described in clinical notes, making them the more reliable source for this level of detail."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0069",
            "originalCriterionId": "EXC_5",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction or intolerance to other monoclonal antibodies",
            "normalizedText": "Prior severe allergic reaction or intolerance to other monoclonal antibodies",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_5_2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 69
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mab_hypersensitivity",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Details of a 'severe allergic reaction or intolerance' to a class of drugs like monoclonal antibodies are most reliably found in the narrative of clinical notes, rather than a structured allergy list. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0069",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Details of a 'severe allergic reaction or intolerance' to a class of drugs like monoclonal antibodies are most reliably found in the narrative of clinical notes, rather than a structured allergy list."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction or intolerance to other monoclonal antibodies",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0070",
            "originalCriterionId": "EXC_5",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction or intolerance to humanized antibodies",
            "normalizedText": "Prior severe allergic reaction or intolerance to humanized antibodies",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_5_3",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 70
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mab_hypersensitivity",
            "expressionNodeId": "3",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Details of a 'severe allergic reaction or intolerance' to a class of drugs like humanized antibodies are most reliably found in the narrative of clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0070",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Details of a 'severe allergic reaction or intolerance' to a class of drugs like humanized antibodies are most reliably found in the narrative of clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction or intolerance to humanized antibodies",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0071",
            "originalCriterionId": "EXC_5",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction or intolerance to chimeric antibodies",
            "normalizedText": "Prior severe allergic reaction or intolerance to chimeric antibodies",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_5_4",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 71
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mab_hypersensitivity",
            "expressionNodeId": "4",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Details of a 'severe allergic reaction or intolerance' to a class of drugs like chimeric antibodies are most reliably found in the narrative of clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0071",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Details of a 'severe allergic reaction or intolerance' to a class of drugs like chimeric antibodies are most reliably found in the narrative of clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction or intolerance to chimeric antibodies",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0072",
            "originalCriterionId": "EXC_6",
            "criterionType": "exclusion",
            "atomicText": "Known immediate hypersensitivity to any component of study treatment",
            "normalizedText": "Known immediate hypersensitivity to any component of study treatment",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_6_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 72
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "A known hypersensitivity, especially the type (immediate), is best described in the patient's history within clinical notes, which provide more context than a structured allergy list. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0072",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "A known hypersensitivity, especially the type (immediate), is best described in the patient's history within clinical notes, which provide more context than a structured allergy list."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Known immediate hypersensitivity to any component of study treatment",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0073",
            "originalCriterionId": "EXC_6",
            "criterionType": "exclusion",
            "atomicText": "Known delayed hypersensitivity to any component of study treatment",
            "normalizedText": "Known delayed hypersensitivity to any component of study treatment",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_6_2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 73
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "A known hypersensitivity, especially the type (delayed), is best described in the patient's history within clinical notes, which provide more context than a structured allergy list. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0073",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "A known hypersensitivity, especially the type (delayed), is best described in the patient's history within clinical notes, which provide more context than a structured allergy list."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Known delayed hypersensitivity to any component of study treatment",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0074",
            "originalCriterionId": "EXC_6",
            "criterionType": "exclusion",
            "atomicText": "Known intolerance to any component of study treatment",
            "normalizedText": "Known intolerance to any component of study treatment",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_6_3",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 74
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
            "expressionNodeId": "3",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "Drug 'intolerance' is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy in structured data. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0074",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Drug 'intolerance' is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy in structured data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Known intolerance to any component of study treatment",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0075",
            "originalCriterionId": "EXC_6",
            "criterionType": "exclusion",
            "atomicText": "Known contraindication to any component of study treatment",
            "normalizedText": "Known contraindication to any component of study treatment",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_6_4",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 75
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
            "expressionNodeId": "4",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.85,
              "reasoning": "A 'contraindication' is a clinical conclusion that could be based on many factors (diagnoses, labs, allergies). The documentation of this conclusion and its reasoning is typically found in the narrative of clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0075",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.85,
                "reasoning": "A 'contraindication' is a clinical conclusion that could be based on many factors (diagnoses, labs, allergies). The documentation of this conclusion and its reasoning is typically found in the narrative of clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Known contraindication to any component of study treatment",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0076",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction to Leucovorin",
            "normalizedText": "Prior severe allergic reaction to Leucovorin",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_7_1a",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 76
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mfolfox6_leucovorin_contraindication",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Details of a 'severe allergic reaction' to a specific drug like Leucovorin are most reliably found in the narrative of clinical notes, which describe the event. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0076",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Details of a 'severe allergic reaction' to a specific drug like Leucovorin are most reliably found in the narrative of clinical notes, which describe the event."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction to Leucovorin",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0077",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction to Fluorouracil",
            "normalizedText": "Prior severe allergic reaction to Fluorouracil",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_7_1b",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 77
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mfolfox6_fluorouracil_contraindication",
            "expressionNodeId": "1b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Details of a 'severe allergic reaction' to a specific drug like Fluorouracil are most reliably found in the narrative of clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0077",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Details of a 'severe allergic reaction' to a specific drug like Fluorouracil are most reliably found in the narrative of clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction to Fluorouracil",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0078",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "atomicText": "Prior severe allergic reaction to Oxaliplatin",
            "normalizedText": "Prior severe allergic reaction to Oxaliplatin",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [
                4273629
              ],
              "conceptNames": [
                "Chemotherapy"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "367336001"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Procedure",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "367336001",
                  "display": "Chemotherapy"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|367336001",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_7_1c",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 78
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mfolfox6_oxaliplatin_contraindication",
            "expressionNodeId": "1c",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "Details of a 'severe allergic reaction' to a specific drug like Oxaliplatin are most reliably found in the narrative of clinical notes. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0078",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Details of a 'severe allergic reaction' to a specific drug like Oxaliplatin are most reliably found in the narrative of clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior severe allergic reaction to Oxaliplatin",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0079",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "atomicText": "Prior intolerance to Leucovorin",
            "normalizedText": "Prior intolerance to Leucovorin",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_7_2a",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 79
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mfolfox6_leucovorin_contraindication",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "Drug 'intolerance' to Leucovorin is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0079",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Drug 'intolerance' to Leucovorin is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior intolerance to Leucovorin",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0080",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "atomicText": "Prior intolerance to Fluorouracil",
            "normalizedText": "Prior intolerance to Fluorouracil",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_7_2b",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 80
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mfolfox6_fluorouracil_contraindication",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "Drug 'intolerance' to Fluorouracil is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0080",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Drug 'intolerance' to Fluorouracil is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior intolerance to Fluorouracil",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0081",
            "originalCriterionId": "EXC_7",
            "criterionType": "exclusion",
            "atomicText": "Prior intolerance to Oxaliplatin",
            "normalizedText": "Prior intolerance to Oxaliplatin",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [
                4273629
              ],
              "conceptNames": [
                "Chemotherapy"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "367336001"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Procedure",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "367336001",
                  "display": "Chemotherapy"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|367336001",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_7_2c",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 81
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "mfolfox6_oxaliplatin_contraindication",
            "expressionNodeId": "2c",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "Drug 'intolerance' to Oxaliplatin is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0081",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.95,
                "reasoning": "Drug 'intolerance' to Oxaliplatin is a nuanced concept often documented with descriptive text in clinical notes rather than a formal, coded allergy."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Prior intolerance to Oxaliplatin",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0082",
            "originalCriterionId": "EXC_8",
            "criterionType": "exclusion",
            "atomicText": "Known dihydropyrimidine dehydrogenase (DPD) deficiency",
            "normalizedText": "Known dihydropyrimidine dehydrogenase (DPD) deficiency",
            "category": "biomarker",
            "funnelImpact": {
              "eliminationRate": 2.0,
              "impactScore": 0.02,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_8_1",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 82
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "DPD deficiency is a genetic condition confirmed by a molecular diagnostic test. The definitive source is the lab or pathology report detailing the test result. No OMOP mapping. Data in: Molecular Diagnostics, Lab Report",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0082",
                "primaryDataSource": "pathology_report",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Molecular Diagnostics",
                  "Lab Report"
                ],
                "confidence": 0.95,
                "reasoning": "DPD deficiency is a genetic condition confirmed by a molecular diagnostic test. The definitive source is the lab or pathology report detailing the test result."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Molecular Diagnostics",
                  "Lab Report"
                ],
                "extractionPrompt": "Extract: Known dihydropyrimidine dehydrogenase (DPD) deficiency",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0083",
            "originalCriterionId": "EXC_9",
            "criterionType": "exclusion",
            "atomicText": "Complete gastric outlet syndrome",
            "normalizedText": "Complete gastric outlet syndrome",
            "category": "disease_indication",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_9_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 83
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_outlet_syndrome",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Gastric outlet syndrome is a clinical diagnosis that would be coded with an ICD code in the patient's problem list or encounter diagnoses, making structured EHR data the primary source. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0083",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Gastric outlet syndrome is a clinical diagnosis that would be coded with an ICD code in the patient's problem list or encounter diagnoses, making structured EHR data the primary source."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Complete gastric outlet syndrome",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0084",
            "originalCriterionId": "EXC_9",
            "criterionType": "exclusion",
            "atomicText": "Partial gastric outlet syndrome",
            "normalizedText": "Partial gastric outlet syndrome",
            "category": "disease_indication",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_9_2a",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 84
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_outlet_syndrome",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Partial gastric outlet syndrome is a clinical diagnosis that would be coded with an ICD code in the patient's problem list or encounter diagnoses. No OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0084",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Partial gastric outlet syndrome is a clinical diagnosis that would be coded with an ICD code in the patient's problem list or encounter diagnoses."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Partial gastric outlet syndrome",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0085",
            "originalCriterionId": "EXC_9",
            "criterionType": "exclusion",
            "atomicText": "Persistent or recurrent vomiting",
            "normalizedText": "Persistent or recurrent vomiting",
            "category": "disease_indication",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_9_2b",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 85
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "This is a clinical symptom. The chronicity and pattern ('persistent or recurrent') are best described in the narrative of clinical notes, such as H&P or progress notes. No OMOP mapping. Data in: H&P, Progress Note, Nursing Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0085",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Nursing Note"
                ],
                "confidence": 0.95,
                "reasoning": "This is a clinical symptom. The chronicity and pattern ('persistent or recurrent') are best described in the narrative of clinical notes, such as H&P or progress notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "Nursing Note"
                ],
                "extractionPrompt": "Extract: Persistent or recurrent vomiting",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0086",
            "originalCriterionId": "EXC_10",
            "criterionType": "exclusion",
            "atomicText": "Significant gastric bleeding",
            "normalizedText": "Significant gastric bleeding",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_10_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 86
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted p...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "Significant gastric bleeding is a diagnosis that would be captured with a standard ICD code in the structured problem list or encounter data. No OMOP mapping. Data in: Discharge Summary, H&P",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0086",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Discharge Summary",
                  "H&P"
                ],
                "confidence": 0.9,
                "reasoning": "Significant gastric bleeding is a diagnosis that would be captured with a standard ICD code in the structured problem list or encounter data."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Discharge Summary",
                  "H&P"
                ],
                "extractionPrompt": "Extract: Significant gastric bleeding",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0087",
            "originalCriterionId": "EXC_10",
            "criterionType": "exclusion",
            "atomicText": "Untreated gastric ulcers",
            "normalizedText": "Untreated gastric ulcers",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_10_2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 87
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted p...",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "The diagnosis of gastric ulcers and their treatment status ('untreated') would be detailed in clinical notes, particularly endoscopy reports and the associated treatment plan documented in progress notes. No OMOP mapping. Data in: H&P, Progress Note, GI/Endoscopy Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0087",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "GI/Endoscopy Note"
                ],
                "confidence": 0.9,
                "reasoning": "The diagnosis of gastric ulcers and their treatment status ('untreated') would be detailed in clinical notes, particularly endoscopy reports and the associated treatment plan documented in progress notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note",
                  "GI/Endoscopy Note"
                ],
                "extractionPrompt": "Extract: Untreated gastric ulcers",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0088",
            "originalCriterionId": "EXC_11",
            "criterionType": "exclusion",
            "atomicText": "History of positive test for Human Immunodeficiency Virus (HIV) infection",
            "normalizedText": "History of positive test for Human Immunodeficiency Virus (HIV) infection",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                439727
              ],
              "conceptNames": [
                "Human immunodeficiency virus infection"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "86406008"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439727)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "86406008",
                  "display": "Human immunodeficiency virus infection"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "B20",
                  "display": "Human immunodeficiency virus [HIV] disease"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|86406008,B20",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_11_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 88
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "viral_infection_exclusion",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.98,
              "reasoning": "A positive HIV test is a definitive lab result, which is stored as structured data. It would also be listed as a diagnosis code in the structured problem list. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0088",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.98,
                "reasoning": "A positive HIV test is a definitive lab result, which is stored as structured data. It would also be listed as a diagnosis code in the structured problem list."
              }
            }
          },
          {
            "atomicId": "A0089",
            "originalCriterionId": "EXC_11",
            "criterionType": "exclusion",
            "atomicText": "Active Hepatitis B infection (positive HBsAg)",
            "normalizedText": "Active Hepatitis B infection (positive HBsAg)",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                439674
              ],
              "conceptNames": [
                "Chronic viral hepatitis B without delta-agent"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "186639003"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439674)",
              "sqlExecutable": true,
              "valueConstraint": "positive Hepatitis B surface antigen (HBsAg) result"
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "186639003",
                  "display": "Chronic viral hepatitis B without delta-agent"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "B18.1",
                  "display": "Chronic viral hepatitis B without delta-agent"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|186639003,B18.1",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_11_2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 89
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "viral_infection_exclusion",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.98,
              "reasoning": "Active Hepatitis B infection is determined by a specific lab test (HBsAg), the result of which is found in structured lab data (LOINC codes). Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0089",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.98,
                "reasoning": "Active Hepatitis B infection is determined by a specific lab test (HBsAg), the result of which is found in structured lab data (LOINC codes)."
              }
            }
          },
          {
            "atomicId": "A0090",
            "originalCriterionId": "EXC_11",
            "criterionType": "exclusion",
            "atomicText": "Active Hepatitis C infection",
            "normalizedText": "Active Hepatitis C infection",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                198964
              ],
              "conceptNames": [
                "Chronic hepatitis C"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "128302006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (198964)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "128302006",
                  "display": "Chronic viral hepatitis C"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "B18.2",
                  "display": "Chronic viral hepatitis C"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|128302006,B18.2",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_11_3",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 90
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ...",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "viral_infection_exclusion",
            "expressionNodeId": "3",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.98,
              "reasoning": "Active Hepatitis C infection is confirmed by laboratory testing (e.g., HCV RNA), and these results are stored as structured data in the EHR. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0090",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 0.98,
                "reasoning": "Active Hepatitis C infection is confirmed by laboratory testing (e.g., HCV RNA), and these results are stored as structured data in the EHR."
              }
            }
          },
          {
            "atomicId": "A0091",
            "originalCriterionId": "EXC_12",
            "criterionType": "exclusion",
            "atomicText": "Active autoimmune disease",
            "normalizedText": "Active autoimmune disease",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                434621
              ],
              "conceptNames": [
                "Autoimmune disease"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "85828009"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (434621)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "85828009",
                  "display": "Autoimmune disease"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|85828009",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_12_1",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 91
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "c. Subjects treated with HCV with undetectable viral load results are eligible.\n12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "While a diagnosis of autoimmune disease may exist as an ICD code in ehr_structured, determining if it is 'active' requires a current clinical assessment documented in notes. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0091",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "While a diagnosis of autoimmune disease may exist as an ICD code in ehr_structured, determining if it is 'active' requires a current clinical assessment documented in notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Active autoimmune disease",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0092",
            "originalCriterionId": "EXC_12",
            "criterionType": "exclusion",
            "atomicText": "Required systemic treatment for autoimmune disease",
            "normalizedText": "Required systemic treatment for autoimmune disease",
            "category": "treatment_history",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_12_2a",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 92
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "c. Subjects treated with HCV with undetectable viral load results are eligible.\n12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "The medication may be in the structured medication list, but confirming it is 'required' and for an 'autoimmune disease' relies on the context provided in clinical notes. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0092",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "The medication may be in the structured medication list, but confirming it is 'required' and for an 'autoimmune disease' relies on the context provided in clinical notes."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Required systemic treatment for autoimmune disease",
                "expectedValues": [],
                "valueType": "numeric",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0093",
            "originalCriterionId": "EXC_13",
            "criterionType": "exclusion",
            "atomicText": "Active infection",
            "normalizedText": "Active infection",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                432250
              ],
              "conceptNames": [
                "Infectious disease"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "40733004"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (432250)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "40733004",
                  "display": "Infectious disease"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|40733004",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_13_1",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 93
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "An infection diagnosis may have an ICD code, but its 'active' status is a current clinical determination found in recent progress notes or the H&P. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0093",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "An infection diagnosis may have an ICD code, but its 'active' status is a current clinical determination found in recent progress notes or the H&P."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Active infection",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0094",
            "originalCriterionId": "EXC_13",
            "criterionType": "exclusion",
            "atomicText": "Requires systemic therapy for infection",
            "normalizedText": "Requires systemic therapy for infection",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4329847
              ],
              "conceptNames": [
                "Myocardial infarction"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "22298006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "22298006",
                  "display": "Myocardial infarction"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "I21.9",
                  "display": "Acute myocardial infarction, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_13_2",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 94
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "fully_queryable",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "Structured medication data shows the prescription, but clinical notes are required to confirm the indication (for infection) and that it is currently required systemic therapy. Has OMOP mapping. Data in: H&P, Progress Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0094",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "confidence": 0.9,
                "reasoning": "Structured medication data shows the prescription, but clinical notes are required to confirm the indication (for infection) and that it is currently required systemic therapy."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "H&P",
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: Requires systemic therapy for infection",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0095",
            "originalCriterionId": "EXC_13",
            "criterionType": "exclusion",
            "atomicText": "Infection has completely resolved",
            "normalizedText": "Infection has completely resolved",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 15.0,
              "impactScore": 0.15,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_13_3a1",
              "groupLogic": "NOT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 95
            },
            "provenance": {
              "pageNumber": 26,
              "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "3a1",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "The resolution of an infection is a clinical assessment and status update that would be documented in a progress note or follow-up summary. No OMOP mapping. Data in: Progress Note, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0095",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": null,
                "noteTypes": [
                  "Progress Note",
                  "Discharge Summary"
                ],
                "confidence": 0.95,
                "reasoning": "The resolution of an infection is a clinical assessment and status update that would be documented in a progress note or follow-up summary."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: Infection has completely resolved",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0096",
            "originalCriterionId": "EXC_14",
            "criterionType": "exclusion",
            "atomicText": "Significant cardiovascular disease",
            "normalizedText": "Significant cardiovascular disease",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 20.0,
              "impactScore": 0.2,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_14_1",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 96
            },
            "provenance": {
              "pageNumber": 65,
              "textSnippet": "13. Subject has active infection requiring systemic therapy that has not completely \nresolved within 7 days prior to randomization.\n14. Subject has significant cardiovascular disease, including any of the following:",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "clinicalConceptGroup": "significant_cardiovascular_disease",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 0.98,
              "reasoning": "The term 'significant' requires a subjective evaluation by the investigator to determine if the patient's known cardiovascular disease poses a risk for the study. No OMOP mapping. Data in: H&P, Cardiology Note",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0096",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "H&P",
                  "Cardiology Note"
                ],
                "confidence": 0.98,
                "reasoning": "The term 'significant' requires a subjective evaluation by the investigator to determine if the patient's known cardiovascular disease poses a risk for the study."
              }
            }
          },
          {
            "atomicId": "A0097",
            "originalCriterionId": "EXC_15",
            "criterionType": "exclusion",
            "atomicText": "History of gastric cancer",
            "normalizedText": "History of gastric cancer",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                196044
              ],
              "conceptNames": [
                "Primary malignant neoplasm of stomach"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "372014001"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "372014001",
                  "display": "Primary malignant neoplasm of stomach"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "C16.9",
                  "display": "Malignant neoplasm of stomach, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|372014001,C16.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_15_1a",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 97
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
              "confidence": 1.0
            },
            "queryableStatus": "fully_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_gej_cancer",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "QUERYABLE",
              "queryableStatus": "fully_queryable",
              "confidence": 0.95,
              "reasoning": "A 'history of' a specific cancer is most reliably found as a diagnosis code (ICD-10) in the patient's structured problem list. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0097",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "pathology_report",
                "noteTypes": [],
                "confidence": 0.95,
                "reasoning": "A 'history of' a specific cancer is most reliably found as a diagnosis code (ICD-10) in the patient's structured problem list."
              }
            }
          },
          {
            "atomicId": "A0098",
            "originalCriterionId": "EXC_15",
            "criterionType": "exclusion",
            "atomicText": "History of gastroesophageal junction (GEJ) cancer",
            "normalizedText": "History of gastroesophageal junction (GEJ) cancer",
            "category": "primary_anchor",
            "funnelImpact": {
              "eliminationRate": 99.9,
              "impactScore": 0.9990000000000001,
              "isKillerCriterion": true
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_15_1b",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 98
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "gastric_gej_cancer",
            "expressionNodeId": "1b",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.95,
              "reasoning": "A 'history of' a specific cancer is most reliably found as a diagnosis code (ICD-10) in the patient's structured problem list. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0098",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "pathology_report",
                "noteTypes": [],
                "confidence": 0.95,
                "reasoning": "A 'history of' a specific cancer is most reliably found as a diagnosis code (ICD-10) in the patient's structured problem list."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Progress Note"
                ],
                "extractionPrompt": "Extract: History of gastroesophageal junction (GEJ) cancer",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0099",
            "originalCriterionId": "EXC_15",
            "criterionType": "exclusion",
            "atomicText": "History of central nervous system metastases",
            "normalizedText": "History of central nervous system metastases",
            "category": "disease_indication",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_15_2a",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 99
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "cns_involvement",
            "expressionNodeId": "2a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.98,
              "reasoning": "The definitive evidence for a history of CNS metastases comes from the original imaging reports (e.g., brain MRI, CT) where the finding was documented. No OMOP mapping. Data in: Radiology",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0099",
                "primaryDataSource": "radiology_report",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Radiology"
                ],
                "confidence": 0.98,
                "reasoning": "The definitive evidence for a history of CNS metastases comes from the original imaging reports (e.g., brain MRI, CT) where the finding was documented."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Radiology"
                ],
                "extractionPrompt": "Extract: History of central nervous system metastases",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0100",
            "originalCriterionId": "EXC_15",
            "criterionType": "exclusion",
            "atomicText": "History of carcinomatous meningitis",
            "normalizedText": "History of carcinomatous meningitis",
            "category": "disease_indication",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                600131150
              ],
              "conceptNames": [
                "Meningeal Carcinomatosis"
              ],
              "vocabularyIds": [
                "NCIt_Full"
              ],
              "conceptCodes": [
                "C27383"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 600131150",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://ncithesaurus-stage.nci.nih.gov",
                  "code": "C27383",
                  "display": "Meningeal Carcinomatosis"
                }
              ],
              "searchParams": "code=http://ncithesaurus-stage.nci.nih.gov|C27383",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_15_2b",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 100
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "disease_indication",
            "stage2QueryableStatus": "fully_queryable",
            "clinicalConceptGroup": "cns_involvement",
            "expressionNodeId": "2b",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.9,
              "reasoning": "This is a specific and serious diagnosis. While it may be confirmed by pathology (cytology), the comprehensive history and clinical context are best captured in oncology progress notes or summaries. Has OMOP mapping. Data in: Oncology Note, H&P, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0100",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "pathology_report",
                "noteTypes": [
                  "Oncology Note",
                  "H&P",
                  "Discharge Summary"
                ],
                "confidence": 0.9,
                "reasoning": "This is a specific and serious diagnosis. While it may be confirmed by pathology (cytology), the comprehensive history and clinical context are best captured in oncology progress notes or summaries."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Oncology Note",
                  "H&P",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: History of carcinomatous meningitis",
                "expectedValues": [],
                "valueType": "boolean",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0101",
            "originalCriterionId": "EXC_16",
            "criterionType": "exclusion",
            "atomicText": "Peripheral sensory neuropathy grade > 1",
            "normalizedText": "Peripheral sensory neuropathy grade > 1",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 20.0,
              "impactScore": 0.2,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [
                4117779
              ],
              "conceptNames": [
                "Peripheral nerve disease"
              ],
              "vocabularyIds": [
                "SNOMED"
              ],
              "conceptCodes": [
                "302226006"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4117779)",
              "sqlExecutable": true,
              "valueConstraint": "value_as_number > 1"
            },
            "fhirQuery": {
              "resourceType": "Condition",
              "codes": [
                {
                  "system": "http://snomed.info/sct",
                  "code": "302226006",
                  "display": "Peripheral nerve disease"
                },
                {
                  "system": "http://hl7.org/fhir/sid/icd-10-cm",
                  "code": "G62.9",
                  "display": "Polyneuropathy, unspecified"
                }
              ],
              "searchParams": "code=http://snomed.info/sct|302226006,G62.9",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_16_1",
              "groupLogic": "EXCEPT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 101
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "clinicalConceptGroup": "peripheral_neuropathy",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "This requires a neurological physical exam and CTCAE grading at the time of screening to establish a baseline and determine eligibility. Has OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0101",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "This requires a neurological physical exam and CTCAE grading at the time of screening to establish a baseline and determine eligibility."
              }
            }
          },
          {
            "atomicId": "A0102",
            "originalCriterionId": "EXC_16",
            "criterionType": "exclusion",
            "atomicText": "Deep tendon reflexes present",
            "normalizedText": "Deep tendon reflexes present",
            "category": "functional",
            "funnelImpact": {
              "eliminationRate": 20.0,
              "impactScore": 0.2,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_16_2a1",
              "groupLogic": "NOT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 102
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2a1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "Assessing deep tendon reflexes is part of a physical examination that must be performed at screening to evaluate the patient's current neurological status. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0102",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Assessing deep tendon reflexes is part of a physical examination that must be performed at screening to evaluate the patient's current neurological status."
              }
            }
          },
          {
            "atomicId": "A0103",
            "originalCriterionId": "EXC_16",
            "criterionType": "exclusion",
            "atomicText": "Other neurological abnormality present",
            "normalizedText": "Other neurological abnormality present",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_16_2b1",
              "groupLogic": "NOT",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 103
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2b1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "Detecting the presence of 'other neurological abnormality' requires a new physical examination at the screening visit. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0103",
                "primaryDataSource": "real_time_assessment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Detecting the presence of 'other neurological abnormality' requires a new physical examination at the screening visit."
              }
            }
          },
          {
            "atomicId": "A0104",
            "originalCriterionId": "EXC_17",
            "criterionType": "exclusion",
            "atomicText": "Had a major surgical procedure",
            "normalizedText": "Had a major surgical procedure",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "procedure_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_17_1a",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 104
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "deep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.",
              "confidence": 1.0
            },
            "queryableStatus": "llm_extractable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "partially_queryable",
            "expressionNodeId": "1a",
            "queryabilityClassification": {
              "category": "LLM_EXTRACTABLE",
              "queryableStatus": "llm_extractable",
              "confidence": 0.9,
              "reasoning": "A major surgical procedure would be recorded with a standard procedure code (CPT, HCPCS) in the structured EHR data. Details would be in the operative note. No OMOP mapping. Data in: Operative Report, Discharge Summary",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0104",
                "primaryDataSource": "ehr_structured",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [
                  "Operative Report",
                  "Discharge Summary"
                ],
                "confidence": 0.9,
                "reasoning": "A major surgical procedure would be recorded with a standard procedure code (CPT, HCPCS) in the structured EHR data. Details would be in the operative note."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Operative Report",
                  "Discharge Summary"
                ],
                "extractionPrompt": "Extract: Had a major surgical procedure",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0105",
            "originalCriterionId": "EXC_18",
            "criterionType": "exclusion",
            "atomicText": "Psychiatric illness that would preclude study compliance per investigator judgment",
            "normalizedText": "Psychiatric illness that would preclude study compliance per investigator judgment",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "condition_occurrence",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_18_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 105
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "a. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "The phrase 'per investigator judgment' makes this a subjective assessment of whether a patient's condition would preclude compliance, which is the definition of clinical judgment. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0105",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The phrase 'per investigator judgment' makes this a subjective assessment of whether a patient's condition would preclude compliance, which is the definition of clinical judgment."
              }
            }
          },
          {
            "atomicId": "A0106",
            "originalCriterionId": "EXC_18",
            "criterionType": "exclusion",
            "atomicText": "Social situations that would preclude study compliance per investigator judgment",
            "normalizedText": "Social situations that would preclude study compliance per investigator judgment",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_18_2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 106
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "a. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "The phrase 'per investigator judgment' makes this a subjective assessment of a patient's social situation, which is the definition of clinical judgment. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0106",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": null,
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "The phrase 'per investigator judgment' makes this a subjective assessment of a patient's social situation, which is the definition of clinical judgment."
              }
            }
          },
          {
            "atomicId": "A0107",
            "originalCriterionId": "EXC_19",
            "criterionType": "exclusion",
            "atomicText": "Another malignancy for which treatment is required",
            "normalizedText": "Another malignancy for which treatment is required",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [
                600055953
              ],
              "conceptNames": [
                "Prior Invasive Malignancy"
              ],
              "vocabularyIds": [
                "NCIt_Full"
              ],
              "conceptCodes": [
                "C154619"
              ],
              "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
              "sqlExecutable": true
            },
            "fhirQuery": {
              "resourceType": "Observation",
              "codes": [
                {
                  "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "code": "C154619",
                  "display": "Prior Invasive Malignancy"
                }
              ],
              "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
              "queryExecutable": true,
              "valueFilter": null,
              "dateFilter": null
            },
            "executionContext": {
              "logicalGroup": "G_EXC_19_1",
              "groupLogic": "AND",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 107
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
              "confidence": 1.0
            },
            "queryableStatus": "hybrid_queryable",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "HYBRID_QUERYABLE",
              "queryableStatus": "hybrid_queryable",
              "confidence": 0.95,
              "reasoning": "Determining if another malignancy 'requires treatment' involves understanding the current care plan, which is detailed in oncology progress notes, not just a diagnosis code. Has OMOP mapping. Data in: Oncology Note, H&P",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0107",
                "primaryDataSource": "clinical_notes",
                "secondaryDataSource": "ehr_structured",
                "noteTypes": [
                  "Oncology Note",
                  "H&P"
                ],
                "confidence": 0.95,
                "reasoning": "Determining if another malignancy 'requires treatment' involves understanding the current care plan, which is detailed in oncology progress notes, not just a diagnosis code."
              },
              "nlpQuerySpec": {
                "noteTypes": [
                  "Oncology Note",
                  "H&P"
                ],
                "extractionPrompt": "Extract: Another malignancy for which treatment is required",
                "expectedValues": [],
                "valueType": "categorical",
                "temporalConstraint": "most_recent",
                "confidenceThreshold": 0.7
              }
            }
          },
          {
            "atomicId": "A0108",
            "originalCriterionId": "EXC_20",
            "criterionType": "exclusion",
            "atomicText": "Concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study",
            "normalizedText": "Concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_20_1",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 108
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "1",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "Determining if a condition 'interferes with the ability of the subject to participate' is a subjective assessment made by the investigator. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0108",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Determining if a condition 'interferes with the ability of the subject to participate' is a subjective assessment made by the investigator."
              }
            }
          },
          {
            "atomicId": "A0109",
            "originalCriterionId": "EXC_20",
            "criterionType": "exclusion",
            "atomicText": "Concurrent disease, infection or comorbid condition that places the subject at undue risk",
            "normalizedText": "Concurrent disease, infection or comorbid condition that places the subject at undue risk",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_20_2",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 109
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "2",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "Assessing whether a condition 'places the subject at undue risk' is a core responsibility of the investigator and represents a subjective clinical judgment. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0109",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Assessing whether a condition 'places the subject at undue risk' is a core responsibility of the investigator and represents a subjective clinical judgment."
              }
            }
          },
          {
            "atomicId": "A0110",
            "originalCriterionId": "EXC_20",
            "criterionType": "exclusion",
            "atomicText": "Concurrent disease, infection or comorbid condition that complicates the interpretation of data",
            "normalizedText": "Concurrent disease, infection or comorbid condition that complicates the interpretation of data",
            "category": "safety_exclusion",
            "funnelImpact": {
              "eliminationRate": 0.0,
              "impactScore": 0.0,
              "isKillerCriterion": false
            },
            "omopQuery": {
              "tableName": "observation",
              "conceptIds": [],
              "conceptNames": [],
              "vocabularyIds": [],
              "conceptCodes": [],
              "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
              "sqlExecutable": false
            },
            "fhirQuery": null,
            "executionContext": {
              "logicalGroup": "G_EXC_20_3",
              "groupLogic": "OR",
              "combineWithPrevious": "NOT",
              "isExclusion": true,
              "sequenceHint": 110
            },
            "provenance": {
              "pageNumber": 66,
              "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
              "confidence": 1.0
            },
            "queryableStatus": "screening_only",
            "nonQueryableReason": "No OMOP concepts mapped",
            "stage2ClinicalCategory": "safety_exclusion",
            "stage2QueryableStatus": "requires_manual",
            "expressionNodeId": "3",
            "queryabilityClassification": {
              "category": "SCREENING_ONLY",
              "queryableStatus": "screening_only",
              "confidence": 1.0,
              "reasoning": "Deciding if a condition 'complicates the interpretation of data' is a subjective assessment made by the investigator based on the study's goals and endpoints. No OMOP mapping.",
              "overridable": true,
              "dataSource": {
                "atomicId": "A0110",
                "primaryDataSource": "clinical_judgment",
                "secondaryDataSource": "clinical_notes",
                "noteTypes": [],
                "confidence": 1.0,
                "reasoning": "Deciding if a condition 'complicates the interpretation of data' is a subjective assessment made by the investigator based on the study's goals and endpoints."
              }
            }
          }
        ],
        "logicalGroups": [
          {
            "qebId": "QEB_INC_1",
            "criterionType": "inclusion",
            "criterionText": "Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent and privacy language as per national regulations (e.g., HIPAA Authorization for US sites) must be obtained from the subject or legally authorized representative (if applicable) prior to any study-related procedures.",
            "clinicalName": "Signed Informed Consent and Privacy Authorization",
            "atomicIds": [
              "A0001"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          },
          {
            "qebId": "QEB_INC_2",
            "criterionType": "inclusion",
            "criterionText": "Subject is considered an adult (e.g., \u2265 18 years of age in the US) according to local regulation at the time of signing the informed consent.",
            "clinicalName": "Adult Age Requirement",
            "atomicIds": [
              "A0002"
            ],
            "funnelStage": 1,
            "funnelStageName": "Primary Diagnosis & Treatment Line",
            "isKiller": false,
            "queryableStatus": "fully_queryable"
          },
          {
            "qebId": "QEB_INC_3",
            "criterionType": "inclusion",
            "criterionText": "Subject agrees not to participate in another interventional study while on study treatment.",
            "clinicalName": "No Concurrent Interventional Study Participation",
            "atomicIds": [
              "A0003"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_4",
            "criterionType": "inclusion",
            "criterionText": "A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test at Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) and a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of the following conditions applies:",
            "clinicalName": "Female Contraception and Pregnancy Status",
            "atomicIds": [
              "A0004",
              "A0005",
              "A0006",
              "A0007"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          },
          {
            "qebId": "QEB_INC_5",
            "criterionType": "inclusion",
            "criterionText": "Female subject must agree not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration.",
            "clinicalName": "Agreement to Refrain from Breastfeeding",
            "atomicIds": [
              "A0008",
              "A0009"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_6",
            "criterionType": "inclusion",
            "criterionText": "Female subject must not donate ova starting at Screening and throughout the study period, and for 9 months after the final administration of oxaliplatin and 6 months after the final administration of all other study drugs.",
            "clinicalName": "Agreement to Refrain from Donating Ova",
            "atomicIds": [
              "A0010",
              "A0011",
              "A0012",
              "A0013"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_7",
            "criterionType": "inclusion",
            "criterionText": "A sexually active male subject with female partner(s) who are of childbearing potential must agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during the treatment period and for at least 6 months after the final study drug administration.",
            "clinicalName": "Male Contraception Requirement",
            "atomicIds": [
              "A0014",
              "A0015",
              "A0016",
              "A0017"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_8",
            "criterionType": "inclusion",
            "criterionText": "Male subject must not donate sperm starting at Screening and throughout the study period and for 6 months after the final study drug administration.",
            "clinicalName": "Agreement to Refrain from Donating Sperm",
            "atomicIds": [
              "A0018",
              "A0019"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_9",
            "criterionType": "inclusion",
            "criterionText": "Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent or use a condom for the duration of the pregnancy or for the time partner is breastfeeding throughout the study period and for 6 months after the final study drug administration.",
            "clinicalName": "Male Contraception with Pregnant/Breastfeeding Partner",
            "atomicIds": [
              "A0020",
              "A0021",
              "A0022",
              "A0023",
              "A0024"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_10",
            "criterionType": "inclusion",
            "criterionText": "Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma.",
            "clinicalName": "Histologically Confirmed Gastric or GEJ Adenocarcinoma",
            "atomicIds": [
              "A0025",
              "A0026",
              "A0027"
            ],
            "funnelStage": 1,
            "funnelStageName": "Primary Diagnosis & Treatment Line",
            "isKiller": true,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_11",
            "criterionType": "inclusion",
            "criterionText": "Subject has radiologically confirmed locally advanced unresectable or metastatic disease within 28 days prior to randomization.",
            "clinicalName": "Confirmed Advanced or Metastatic Disease",
            "atomicIds": [
              "A0028",
              "A0029",
              "A0030"
            ],
            "funnelStage": 1,
            "funnelStageName": "Primary Diagnosis & Treatment Line",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_12",
            "criterionType": "inclusion",
            "criterionText": "Subject has radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects with only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion must either be outside the field of prior radiotherapy or have documented progression following radiation therapy.",
            "clinicalName": "Radiologically Evaluable Disease per RECIST 1.1",
            "atomicIds": [
              "A0031",
              "A0032",
              "A0033",
              "A0034",
              "A0035"
            ],
            "funnelStage": 6,
            "funnelStageName": "Screening Labs & Imaging Confirmation",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          },
          {
            "qebId": "QEB_INC_13",
            "criterionType": "inclusion",
            "criterionText": "Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong membranous staining as determined by central IHC testing.",
            "clinicalName": "Positive CLDN18.2 Tumor Expression",
            "atomicIds": [
              "A0036",
              "A0037",
              "A0038",
              "A0039"
            ],
            "funnelStage": 2,
            "funnelStageName": "Tumor Biomarker Profile (CLDN18.2+/HER2-)",
            "isKiller": true,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_14",
            "criterionType": "inclusion",
            "criterionText": "Subject has a known HER2-negative tumor as determined by local or central testing on a gastric or GEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ tumor.)",
            "clinicalName": "Known HER2-Negative Tumor Status",
            "atomicIds": [
              "A0040",
              "A0041",
              "A0042",
              "A0043"
            ],
            "funnelStage": 2,
            "funnelStageName": "Tumor Biomarker Profile (CLDN18.2+/HER2-)",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_INC_15",
            "criterionType": "inclusion",
            "criterionText": "Subject has ECOG performance status 0 to 1.",
            "clinicalName": "Good ECOG Performance Status (0-1)",
            "atomicIds": [
              "A0044"
            ],
            "funnelStage": 3,
            "funnelStageName": "Clinical Performance & Prognostic Assessment",
            "isKiller": false,
            "queryableStatus": "partially_queryable"
          },
          {
            "qebId": "QEB_INC_16",
            "criterionType": "inclusion",
            "criterionText": "Subject has predicted life expectancy \u2265 12 weeks in the opinion of the investigator.",
            "clinicalName": "Adequate Life Expectancy (\u2265 12 weeks)",
            "atomicIds": [
              "A0045"
            ],
            "funnelStage": 3,
            "funnelStageName": "Clinical Performance & Prognostic Assessment",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          },
          {
            "qebId": "QEB_INC_17",
            "criterionType": "inclusion",
            "criterionText": "Subject must meet all of the following criteria based on the centrally or locally analyzed laboratory tests collected within 14 days prior to randomization. In the case of multiple sample collections within this period, the most recent sample collection with available results should be used to determine eligibility.",
            "clinicalName": "Adequate Organ Function via Recent Labs",
            "atomicIds": [
              "A0046"
            ],
            "funnelStage": 6,
            "funnelStageName": "Screening Labs & Imaging Confirmation",
            "isKiller": false,
            "queryableStatus": "partially_queryable"
          },
          {
            "qebId": "QEB_EXC_1",
            "criterionType": "exclusion",
            "criterionText": "Subject has received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo-adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as long as it was completed at least 6 months prior to randomization. Subject may have received treatment with herbal medications that have known antitumor activity > 28 days prior to randomization.",
            "clinicalName": "No Prior Systemic Therapy for Advanced Disease",
            "atomicIds": [
              "A0047",
              "A0048",
              "A0049",
              "A0050",
              "A0051",
              "A0052",
              "A0053"
            ],
            "funnelStage": 1,
            "funnelStageName": "Primary Diagnosis & Treatment Line",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_2",
            "criterionType": "exclusion",
            "criterionText": "Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related toxicity.",
            "clinicalName": "Recent Radiotherapy with Unresolved Toxicity",
            "atomicIds": [
              "A0054",
              "A0055",
              "A0056",
              "A0057",
              "A0058",
              "A0059"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_3",
            "criterionType": "exclusion",
            "criterionText": "Subject has received systemic immunosuppressive therapy, including systemic corticosteroids within 14 days prior to randomization. Subjects using a physiologic replacement dose of hydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 mg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.",
            "clinicalName": "Recent Systemic Immunosuppressive Therapy",
            "atomicIds": [
              "A0060",
              "A0061",
              "A0062",
              "A0063",
              "A0064",
              "A0065"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "hybrid_queryable"
          },
          {
            "qebId": "QEB_EXC_4",
            "criterionType": "exclusion",
            "criterionText": "Subject has received other investigational agents or devices within 28 days prior to randomization.",
            "clinicalName": "Prior Investigational Agent or Device",
            "atomicIds": [
              "A0066",
              "A0067"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_5",
            "criterionType": "exclusion",
            "criterionText": "Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab or other monoclonal antibodies, including humanized or chimeric antibodies.",
            "clinicalName": "Known Hypersensitivity to Monoclonal Antibodies",
            "atomicIds": [
              "A0068",
              "A0069",
              "A0070",
              "A0071"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_6",
            "criterionType": "exclusion",
            "criterionText": "Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to any component of study treatment.",
            "clinicalName": "Known Hypersensitivity to Study Treatment Components",
            "atomicIds": [
              "A0072",
              "A0073",
              "A0074",
              "A0075"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_7",
            "criterionType": "exclusion",
            "criterionText": "Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
            "clinicalName": "Known Hypersensitivity to mFOLFOX6 Components",
            "atomicIds": [
              "A0076",
              "A0077",
              "A0078",
              "A0079",
              "A0080",
              "A0081"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_8",
            "criterionType": "exclusion",
            "criterionText": "Subject has known dihydropyrimidine dehydrogenase (DPD) deficiency. (NOTE: Screening for DPD deficiency should be conducted per local requirements.)",
            "clinicalName": "Known Dihydropyrimidine Dehydrogenase (DPD) Deficiency",
            "atomicIds": [
              "A0082"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_9",
            "criterionType": "exclusion",
            "criterionText": "Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with persistent/recurrent vomiting.",
            "clinicalName": "Symptomatic Gastric Outlet Obstruction",
            "atomicIds": [
              "A0083",
              "A0084",
              "A0085"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_10",
            "criterionType": "exclusion",
            "criterionText": "Per investigator judgment, subject has significant gastric bleeding and/or untreated gastric ulcers that would exclude the subject from participation per investigator judgment.",
            "clinicalName": "Significant Gastric Bleeding or Ulcers",
            "atomicIds": [
              "A0086",
              "A0087"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_11",
            "criterionType": "exclusion",
            "criterionText": "Subject has a known history of a positive test for human immunodeficiency virus (HIV) infection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for these infections should be conducted per local requirements.",
            "clinicalName": "Active HIV, Hepatitis B, or Hepatitis C Infection",
            "atomicIds": [
              "A0088",
              "A0089",
              "A0090"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "fully_queryable"
          },
          {
            "qebId": "QEB_EXC_12",
            "criterionType": "exclusion",
            "criterionText": "Subject has an active autoimmune disease that has required systemic treatment within the past 3 months prior to randomization.",
            "clinicalName": "Active Autoimmune Disease Requiring Systemic Therapy",
            "atomicIds": [
              "A0091",
              "A0092"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "hybrid_queryable"
          },
          {
            "qebId": "QEB_EXC_13",
            "criterionType": "exclusion",
            "criterionText": "Subject has active infection requiring systemic therapy that has not completely resolved within 7 days prior to randomization.",
            "clinicalName": "Active Unresolved Systemic Infection",
            "atomicIds": [
              "A0093",
              "A0094",
              "A0095"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_14",
            "criterionType": "exclusion",
            "criterionText": "Subject has significant cardiovascular disease, including any of the following:",
            "clinicalName": "Significant Cardiovascular Disease",
            "atomicIds": [
              "A0096"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "partially_queryable"
          },
          {
            "qebId": "QEB_EXC_15",
            "criterionType": "exclusion",
            "criterionText": "Subject has history of central nervous system metastases and/or carcinomatous meningitis from gastric/GEJ cancer.",
            "clinicalName": "History of CNS Metastases or Carcinomatous Meningitis",
            "atomicIds": [
              "A0097",
              "A0098",
              "A0099",
              "A0100"
            ],
            "funnelStage": 3,
            "funnelStageName": "Clinical Performance & Prognostic Assessment",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_16",
            "criterionType": "exclusion",
            "criterionText": "Subject has known peripheral sensory neuropathy > grade 1 unless the absence of deep tendon reflexes is the sole neurological abnormality.",
            "clinicalName": "Pre-existing Significant Peripheral Neuropathy (> Grade 1)",
            "atomicIds": [
              "A0101",
              "A0102",
              "A0103"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          },
          {
            "qebId": "QEB_EXC_17",
            "criterionType": "exclusion",
            "criterionText": "Subject has had a major surgical procedure \u2264 28 days prior to randomization.",
            "clinicalName": "Major Surgery Within 28 Days",
            "atomicIds": [
              "A0104"
            ],
            "funnelStage": 5,
            "funnelStageName": "Recent Interventions & Active Conditions",
            "isKiller": false,
            "queryableStatus": "llm_extractable"
          },
          {
            "qebId": "QEB_EXC_18",
            "criterionType": "exclusion",
            "criterionText": "Subject has psychiatric illness or social situations that would preclude study compliance, per investigator judgment.",
            "clinicalName": "Psychiatric or Social Condition Impeding Compliance",
            "atomicIds": [
              "A0105",
              "A0106"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          },
          {
            "qebId": "QEB_EXC_19",
            "criterionType": "exclusion",
            "criterionText": "Subject has another malignancy for which treatment is required per investigator\u2019s clinical judgment.",
            "clinicalName": "Concurrent Malignancy Requiring Active Treatment",
            "atomicIds": [
              "A0107"
            ],
            "funnelStage": 4,
            "funnelStageName": "Comprehensive Medical History & Contraindications",
            "isKiller": false,
            "queryableStatus": "hybrid_queryable"
          },
          {
            "qebId": "QEB_EXC_20",
            "criterionType": "exclusion",
            "criterionText": "Subject has any concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study, which places the subject at undue risk or complicates the interpretation of data in the opinion of the investigator.",
            "clinicalName": "Other Conditions Affecting Safety or Compliance",
            "atomicIds": [
              "A0108",
              "A0109",
              "A0110"
            ],
            "funnelStage": 7,
            "funnelStageName": "Informed Consent & Study Commitments",
            "isKiller": false,
            "queryableStatus": "requires_manual"
          }
        ],
        "processingMetadata": {
          "processingTimeSeconds": 403.16130018234253,
          "llmModelUsed": "gemini-2.5-pro",
          "stageInputsUsed": [
            "stage2",
            "stage11_eligibility_funnel"
          ],
          "llmWarnings": []
        }
      },
      "summary": {
        "totalQEBs": 37,
        "inclusionQEBs": 17,
        "exclusionQEBs": 20,
        "fullyQueryable": 2,
        "llmExtractable": 22,
        "hybridQueryable": 3,
        "screeningOnly": 0,
        "notApplicable": 0,
        "partiallyQueryable": 3,
        "requiresManualReview": 7,
        "totalAtomicsConsolidated": 110,
        "uniqueOmopConcepts": 21,
        "deduplicationRate": 0.8090909090909091,
        "killerCriteriaCount": 2,
        "funnelStagesCount": 7,
        "eligibilitySectionPages": {
          "start": 63,
          "end": 66
        }
      },
      "llm_warnings": [],
      "atomic_validation": {
        "is_valid": true,
        "mismatches": [],
        "warnings": [],
        "total_stage2_atomics": 110,
        "total_funnel_atomics": 110,
        "criteria_with_mismatches": 0,
        "validation_timestamp": "2026-02-13T14:43:01.445481"
      },
      "atomic_validation_passed": true
    },
    "errors": [],
    "warnings": []
  },
  "output_files": [
    "/home/runner/workspace/backend_vNext/protocols/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)/eligibility_output/20260213_142114/20260213_142114/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)_eligibility_criteria.json",
    "/home/runner/workspace/backend_vNext/protocols/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)/eligibility_output/20260213_142114/20260213_142114/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)_eligibility_quality.json",
    "/home/runner/workspace/backend_vNext/protocols/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)/eligibility_output/20260213_142114/20260213_142114/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)_interpretation_result.json",
    "/home/runner/workspace/backend_vNext/protocols/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)/eligibility_output/20260213_142114/20260213_142114/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)_sql_templates.json",
    "/home/runner/workspace/backend_vNext/protocols/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)/eligibility_output/20260213_142114/20260213_142114/SPOTLIGHT (ISN 8951-CL-0301, Phase 3)_omop_mappings.json"
  ]
}